563 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp00570 | [L9]-P18 | KWKLFKKILKFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 3 µM |
| dbacp00571 | [L9]-P18 | KWKLFKKILKFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | Jurkat | Blood cancer | IC50 : 9 µM |
| dbacp00572 | [L9]-P18 | KWKLFKKILKFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | K-562 | Leukemia cancer | IC50 : 3 µM |
| dbacp00618 | [S9]-P18 | KWKLFKKISKFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 4 µM |
| dbacp00619 | [S9]-P18 | KWKLFKKISKFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | Jurkat | Blood cancer | IC50 : 7 µM |
| dbacp00620 | [S9]-P18 | KWKLFKKISKFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | K-562 | Leukemia cancer | IC50 : 3 µM |
| dbacp00739 | 9R | RRRRRNWMWC | Not found | Cell membrane disintegration; Apoptosis | MTT/MTS assay | LNCaP | Prostate cancer | IC50 : 44 µM |
| dbacp00740 | 9R | RRRRRNWMWC | Not found | Cell membrane disintegration; Apoptosis | MTT/MTS assay | LNCaP | Prostate cancer | IC50 : 23 µM |
| dbacp00741 | 9R | RRRRRNWMWC | Not found | Cell membrane disintegration; Apoptosis | MTT/MTS assay | LNCaP | Prostate cancer | IC50 : 28 µM |
| dbacp00742 | 9R | RRRRRNWMWC | Not found | Cell membrane disintegration; Apoptosis | MTT/MTS assay | MDA-MB-231 | Breast cancer | IC50 : 39 µM |
| dbacp00743 | 9R | RRRRRNWMWC | Not found | Cell membrane disintegration; Apoptosis | MTT/MTS assay | MDA-MB-231 | Breast cancer | IC50 : 29 µM |
| dbacp00744 | 9R | RRRRRNWMWC | Not found | Cell membrane disintegration; Apoptosis | MTT/MTS assay | MDA-MB-231 | Breast cancer | IC50 : 16 µM |
| dbacp00745 | 9R | RRRRRNWMWC | Not found | Cell membrane disintegration; Apoptosis | MTT/MTS assay | HUT-102 | Lymphoma cancer | IC50 : 93 µM |
| dbacp00746 | 9R | RRRRRNWMWC | Not found | Cell membrane disintegration; Apoptosis | MTT/MTS assay | HUT-102 | Lymphoma cancer | IC50 : 39 µM |
| dbacp00747 | 9R | RRRRRNWMWC | Not found | Cell membrane disintegration; Apoptosis | MTT/MTS assay | HUT-102 | Lymphoma cancer | IC50 : 37 µM |
| dbacp00748 | 9R | RRRRRNWMWC | Not found | Cell membrane disintegration; Apoptosis | MTT/MTS assay | HUT-102 | Lymphoma cancer | IC50 : 36 µM |
| dbacp00749 | 9R | RRRRRNWMWC | Not found | Cell membrane disintegration; Apoptosis | MTT/MTS assay | HUT-102 | Lymphoma cancer | IC50 : 25 µM |
| dbacp00750 | 9R | RRRRRNWMWC | Not found | Cell membrane disintegration; Apoptosis | MTT/MTS assay | J774A.1 | Tumor | IC50 : 47 µM |
| dbacp00751 | 9R | RRRRRNWMWC | Not found | Cell membrane disintegration; Apoptosis | MTT/MTS assay | J774A.1 | Tumor | IC50 : 12 µM |
| dbacp00752 | 9S1R | RRRRRWCMNW | Not found | Cell membrane disintegration; Apoptosis | MTT/MTS assay | LNCaP | Prostate cancer | IC50 : 26 µM |
| dbacp00753 | 9S1R | RRRRRWCMNW | Not found | Cell membrane disintegration; Apoptosis | MTT/MTS assay | LNCaP | Prostate cancer | IC50 : 9 µM |
| dbacp00754 | 9S1R | RRRRRWCMNW | Not found | Cell membrane disintegration; Apoptosis | MTT/MTS assay | LNCaP | Prostate cancer | IC50 : 8 µM |
| dbacp00755 | 9S1R | RRRRRWCMNW | Not found | Cell membrane disintegration; Apoptosis | MTT/MTS assay | MDA-MB-231 | Breast cancer | IC50 : 18 µM |
| dbacp00756 | 9S1R | RRRRRWCMNW | Not found | Cell membrane disintegration; Apoptosis | MTT/MTS assay | MDA-MB-231 | Breast cancer | IC50 : 12 µM |
| dbacp00757 | 9S1R | RRRRRWCMNW | Not found | Cell membrane disintegration; Apoptosis | MTT/MTS assay | MDA-MB-231 | Breast cancer | IC50 : 10 µM |
| dbacp00758 | 9S1R | RRRRRWCMNW | Not found | Cell membrane disintegration; Apoptosis | MTT/MTS assay | HUT-102 | Lymphoma cancer | IC50 : 38 µM |
| dbacp00759 | 9S1R | RRRRRWCMNW | Not found | Cell membrane disintegration; Apoptosis | MTT/MTS assay | HUT-102 | Lymphoma cancer | IC50 : 43 µM |
| dbacp00760 | 9S1R | RRRRRWCMNW | Nullomer derived anticancer peptides (NulloPs) | Cell membrane disintegration; Apoptosis | MTT/MTS assay | HUT-102 | Lymphoma cancer | IC50 : 43 µM |
| dbacp00761 | 9S1R | RRRRRWCMNW | Nullomer derived anticancer peptides (NulloPs) | Cell membrane disintegration; Apoptosis | MTT/MTS assay | HUT-102 | Lymphoma cancer | IC50 : 45 µM |
| dbacp00762 | 9S1R | RRRRRWCMNW | Nullomer derived anticancer peptides (NulloPs) | Cell membrane disintegration; Apoptosis | MTT/MTS assay | HUT-102 | Lymphoma cancer | IC50 : 36 µM |
| dbacp00763 | 9S1R | RRRRRWCMNW | Nullomer derived anticancer peptides (NulloPs) | Cell membrane disintegration; Apoptosis | MTT/MTS assay | J774A.1 | Tumor | IC50 : 26 µM |
| dbacp00764 | 9S1R | RRRRRWCMNW | Nullomer derived anticancer peptides (NulloPs) | Cell membrane disintegration; Apoptosis | MTT/MTS assay | J774A.1 | Tumor | IC50 : 17 µM |
| dbacp00805 | A4K14-citropin1.1 | GLFAVIKKVASVIKGL | Synthetic construct | Cell membrane disintegration | CCK-8 test | C4-2B | Prostate cancer | IC50 : 29.05 μM |
| dbacp00806 | A4K14-citropin1.1 | GLFAVIKKVASVIKGL | Synthetic construct | Cell membrane disintegration | CCK-8 test | C4-2B | Lung cancer | IC50 : 29.05 μM |
| dbacp00807 | A4K14-citropin1.1 | GLFAVIKKVASVIKGL | Synthetic construct | Cell membrane disintegration | CCK-8 test | A549 | Prostate cancer | IC50 : 14.97 μM |
| dbacp00808 | A4K14-citropin1.1 | GLFAVIKKVASVIKGL | Synthetic construct | Cell membrane disintegration | CCK-8 test | A549 | Lung cancer | IC50 : 14.97 μM |
| dbacp00809 | A4K14-citropin1.1 | GLFAVIKKVASVIKGL | Synthetic construct | Cell membrane disintegration | CCK-8 test | U87 | Prostate cancer | IC50 : 14.8 μM |
| dbacp00810 | A4K14-citropin1.1 | GLFAVIKKVASVIKGL | Synthetic construct | Cell membrane disintegration | CCK-8 test | U87 | Lung cancer | IC50 : 14.8 μM |
| dbacp00811 | A4K14-citropin1.1 | GLFAVIKKVASVIKGL | Synthetic construct | Cell membrane disintegration | CCK-8 test | MCF-7 | Prostate cancer | IC50 : 14.16 μM |
| dbacp00812 | A4K14-citropin1.1 | GLFAVIKKVASVIKGL | Synthetic construct | Cell membrane disintegration | CCK-8 test | MCF-7 | Lung cancer | IC50 : 14.16 μM |
| dbacp00979 | Adenoregulin | GLWSKIKEVGKEAAKAAAKAAGKAALGAVSEAV | South American frog, Giant leaf frog | Cell membrane disintegration | LDH leakage assay | PC-3 | Prostate cancer | GI50 : 1.24 ± 0.23 µM |
| dbacp00980 | Adenoregulin | GLWSKIKEVGKEAAKAAAKAAGKAALGAVSEAV | South American frog, Giant leaf frog | Cell membrane disintegration | LDH leakage assay | LNCaP | Prostate cancer | GI50 : 0.31 ± 0.15 µM |
| dbacp00981 | Adenoregulin | GLWSKIKEVGKEAAKAAAKAAGKAALGAVSEAV | South American frog, Giant leaf frog | Cell membrane disintegration | LDH leakage assay | DU-145 | Liver cancer | GI50 : 0.91 ± 0.04 µM |
| dbacp00982 | Adenoregulin | GLWSKIKEVGKEAAKAAAKAAGKAALGAVSEAV | South American frog, Giant leaf frog | Cell membrane disintegration | LDH leakage assay | MDA-MB-231 | Breast cancer | GI50 : 8.06 ± 0.50 µM |
| dbacp00983 | Adenoregulin | GLWSKIKEVGKEAAKAAAKAAGKAALGAVSEAV | South American frog, Giant leaf frog | Cell membrane disintegration | LDH leakage assay | Raji | Lymphoma cancer | GI50 : 2.57 ± 0.75 µM |
| dbacp00999 | Alloferon 1 | HGVSGHGQHGVHG | Blow fly | Cell membrane disintegration | Not specified | Not found | Skin cancer | Not found |
| dbacp01009 | Alyteserin-2a | ILGKLLSTAAGLLSNL | The European midwife toad, Common midwife toad | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp01180 | Apo E | LRVRLASHLRKLRKRLLRDADDLQKRLAVY | Apoprotein E | Cell membrane disintegration | MTT/MTS assay | PANC-1 | Pancreatic cancer | 55 % Cytotoxity at 40 µg/ml |
| dbacp01181 | Apo E | LRVRLASHLRKLRKRLLRDADDLQKRLAVY | Apoprotein E | Cell membrane disintegration | MTT/MTS assay | Paca-2 | Pancreatic cancer | 55 % Cytotoxity at 40 µg/ml |
| dbacp01182 | Apo E | LRVRLASHLRKLRKRLLRDADDLQKRLAVY | Apoprotein E | Cell membrane disintegration | MTT/MTS assay | MKN-1 | Gastric cancer | 60 % Cytotoxity at 40 µg/ml |
| dbacp01183 | Apo E | LRVRLASHLRKLRKRLLRDADDLQKRLAVY | Apoprotein E | Cell membrane disintegration | MTT/MTS assay | MKN-7 | Gastric cancer | 35 % Cytotoxity at 40 µg/ml |
| dbacp01184 | Apo E | LRVRLASHLRKLRKRLLRDADDLQKRLAVY | Apoprotein E | Cell membrane disintegration | MTT/MTS assay | COLO-201 | Colon cancer | 65 % Cytotoxity at 40 µg/ml |
| dbacp01189 | Ascaphin-8 | GFKDLLKGAAKALVKTVLF | Coastal Tailed Frog, Pacific Northwest, USA, North America | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp01191 | Ascaphin-8 | GFKDLLKGAAKALVKTVLF | Coastal Tailed Frog, Pacific Northwest, USA, North America | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp01238 | Aurein 1.1 | GLFDIIKKIAESI | Green and Golden Bell Frog, Australia | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp01292 | Aurein-1.3 | GLFDIIKKIAESF | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | MOLT-4 | Leukemia | IC50 : 4-5 μM |
| dbacp01293 | Aurein-1.3 | GLFDIIKKIAESF | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | HOP-62 | Lung cancer | IC50 : 5 μM |
| dbacp01294 | Aurein-1.3 | GLFDIIKKIAESF | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | HCT-15 | Colon cancer | IC50 : 4-5 μM |
| dbacp01295 | Aurein-1.3 | GLFDIIKKIAESF | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | SF-539 | CNS cancer | IC50 : 5 μM |
| dbacp01296 | Aurein-1.3 | GLFDIIKKIAESF | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | MDA-MB-435 | Melanoma | IC50 : 5 μM |
| dbacp01297 | Aurein-1.3 | GLFDIIKKIAESF | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | OVCAR-4 | Ovarian cancer | IC50 : 5 μM |
| dbacp01298 | Aurein-1.3 | GLFDIIKKIAESF | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | CAKI-1 | Renal cancer | IC50 : 5 μM |
| dbacp01299 | Aurein-1.3 | GLFDIIKKIAESF | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | Not found | Prostate cancer | IC50 : 5 μM |
| dbacp01300 | Aurein-1.3 | GLFDIIKKIAESF | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | MDA-MB-468 | Breast cancer | IC50 : 5 μM |
| dbacp01302 | Aurein-2.1 [Cleaved into: Aurein-2.1.1] | GLLDIVKKVVGAFGSL | Southern bell frog | Cell membrane disintegration | Not specified | Not specified | Not specified | LC50 : 10⁻⁵ to 10⁻⁴ M |
| dbacp01303 | Aurein-2.1 [Cleaved into: Aurein-2.1.1] | GLLDIVKKVVGAFGSL | Green and golden bell frog | Cell membrane disintegration | Not specified | Not specified | Not specified | LC50 : 10⁻⁵ to 10⁻⁴ M |
| dbacp01304 | Aurein-2.2 (Frogs, amphibians, animals) | GLFDIVKKVVGALGSL | Green; also golden bell frog | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp01307 | Aurein-2.3 | GLFDIVKKVVGAIGSL | Green; also golden bell frog | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp01308 | Aurein-2.4 | GLFDIVKKVVGTLAGL | Green; also golden bell frog | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp01309 | Aurein-2.4 [Cleaved into: Aurein-2.4.1] | GLFDIVKKVVGTIAGL | Green and golden bell frog | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp01310 | Aurein-2.4 [Cleaved into: Aurein-2.4.1] | GLFDIVKKVVGTIAGL | Green and golden bell frog | Cell membrane disintegration | Not specified | Not specified | Not specified | LC50 : 10-5 - 10-4 M |
| dbacp01329 | Aurein-2.5 | GLFDIVKKVVGAFGSL | Green and golden bell frog | Cell membrane disintegration | One-dose and five-dose assay | K-562 | Leukemia | IC50 : 4-5 μM |
| dbacp01330 | Aurein-2.5 | GLFDIVKKVVGAFGSL | Green and golden bell frog | Cell membrane disintegration | One-dose and five-dose assay | HOP-92 | Lung cancer | IC50 : 5 μM |
| dbacp01331 | Aurein-2.5 | GLFDIVKKVVGAFGSL | Green and golden bell frog | Cell membrane disintegration | One-dose and five-dose assay | HCT-116 | Colon cancer | IC50 : 4-5 μM |
| dbacp01332 | Aurein-2.5 | GLFDIVKKVVGAFGSL | Green and golden bell frog | Cell membrane disintegration | One-dose and five-dose assay | SNB-19 | CNS cancer | IC50 : 5 μM |
| dbacp01333 | Aurein-2.5 | GLFDIVKKVVGAFGSL | Green and golden bell frog | Cell membrane disintegration | One-dose and five-dose assay | M14 | Melanoma | IC50 : 5 μM |
| dbacp01334 | Aurein-2.5 | GLFDIVKKVVGAFGSL | Green and golden bell frog | Cell membrane disintegration | One-dose and five-dose assay | OVCAR-5 | Ovarian cancer | IC50 : 5 μM |
| dbacp01335 | Aurein-2.5 | GLFDIVKKVVGAFGSL | Green and golden bell frog | Cell membrane disintegration | One-dose and five-dose assay | ACHN | Renal cancer | IC50 : 5 μM |
| dbacp01336 | Aurein-2.5 | GLFDIVKKVVGAFGSL | Green and golden bell frog | Cell membrane disintegration | One-dose and five-dose assay | Not found | Prostate cancer | IC50 : 5 μM |
| dbacp01337 | Aurein-2.5 | GLFDIVKKVVGAFGSL | Green and golden bell frog | Cell membrane disintegration | One-dose and five-dose assay | HS 578T | Breast cancer | IC50 : 5 μM |
| dbacp01347 | Aurein-2.7 | GLFDIAKKVIGVIGSL | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | RPMI-8226 | Leukemia | IC50 : 4-5 μM |
| dbacp01348 | Aurein-2.7 | GLFDIAKKVIGVIGSL | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | EKVX | Lung cancer | IC50 : 5 μM |
| dbacp01349 | Aurein-2.7 | GLFDIAKKVIGVIGSL | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | HT29 | Colon cancer | IC50 : 4-5 μM |
| dbacp01350 | Aurein-2.7 | GLFDIAKKVIGVIGSL | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | SF-295 | CNS cancer | IC50 : 5 μM |
| dbacp01351 | Aurein-2.7 | GLFDIAKKVIGVIGSL | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | SK-MEL-2 | Melanoma | IC50 : 5 μM |
| dbacp01352 | Aurein-2.7 | GLFDIAKKVIGVIGSL | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | OVCAR-3 | Ovarian cancer | IC50 : 5 μM |
| dbacp01353 | Aurein-2.7 | GLFDIAKKVIGVIGSL | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | RXF 393 | Renal cancer | IC50 : 5 μM |
| dbacp01354 | Aurein-2.7 | GLFDIAKKVIGVIGSL | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | DU-145 | Prostate cancer | IC50 : 5 μM |
| dbacp01355 | Aurein-2.7 | GLFDIAKKVIGVIGSL | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | MDA-MB-231/ATCC | Breast cancer | IC50 : 5 μM |
| dbacp01356 | Aurein-2.7 | GLFDIVKKIAGHIVSSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | SR | Leukemia | IC50 : 4-5 μM |
| dbacp01358 | Aurein-3.1 [Cleaved into: Aurein-3.1.1; Aurein-3.1.2] | GLFDIVKKIAGHIAGSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | CCRF-CEM | Leukemia | IC50 : 4-5 μM |
| dbacp01359 | Aurein-3.1 [Cleaved into: Aurein-3.1.1; Aurein-3.1.2] | GLFDIVKKIAGHIAGSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | NCI-H23 | Lung cancer | IC50 : 5 μM |
| dbacp01360 | Aurein-3.1 [Cleaved into: Aurein-3.1.1; Aurein-3.1.2] | GLFDIVKKIAGHIAGSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | COLO 205 | Colon cancer | IC50 : 4-5 μM |
| dbacp01361 | Aurein-3.1 [Cleaved into: Aurein-3.1.1; Aurein-3.1.2] | GLFDIVKKIAGHIAGSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | U251 | CNS cancer | IC50 : 5 μM |
| dbacp01362 | Aurein-3.1 [Cleaved into: Aurein-3.1.1; Aurein-3.1.2] | GLFDIVKKIAGHIAGSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | LOX IMVI | Melanoma | IC50 : 5 μM |
| dbacp01363 | Aurein-3.1 [Cleaved into: Aurein-3.1.1; Aurein-3.1.2] | GLFDIVKKIAGHIAGSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | NCI/ADR-RES | Ovarian cancer | IC50 : 5 μM |
| dbacp01364 | Aurein-3.1 [Cleaved into: Aurein-3.1.1; Aurein-3.1.2] | GLFDIVKKIAGHIAGSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | 786-0 | Renal cancer | IC50 : 5 μM |
| dbacp01365 | Aurein-3.1 [Cleaved into: Aurein-3.1.1; Aurein-3.1.2] | GLFDIVKKIAGHIAGSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | Not found | Prostate cancer | IC50 : 5 μM |
| dbacp01366 | Aurein-3.1 [Cleaved into: Aurein-3.1.1; Aurein-3.1.2] | GLFDIVKKIAGHIAGSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | BT-549 | Breast cancer | IC50 : 5 μM |
| dbacp01368 | Aurein-3.1 [Cleaved into: Aurein-3.1.1; Aurein-3.1.2] | GLFDIVKKIAGHIAGSI | Southern bell frog | Cell membrane disintegration | Not specified | Not specified | Not specified | LC50 : 10⁻⁵ - 10⁻⁴ M |
| dbacp01369 | Aurein-3.1.1 | GLFDIVKKIAGHIA | Green and golden bell frog | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp01370 | Aurein-3.1.2 | FDIVKKIAGHIAGSI | Green and golden bell frog | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp01371 | Aurein-3.2 | GLFDIVKKIAGHIASSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | HL-60(TB) | Leukemia | IC50 : 4-5 μM |
| dbacp01372 | Aurein-3.2 | GLFDIVKKIAGHIASSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | NCI-H226 | Lung cancer | IC50 : 5 μM |
| dbacp01373 | Aurein-3.2 | GLFDIVKKIAGHIASSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | HCC-2998 | Colon cancer | IC50 : 4-5 μM |
| dbacp01374 | Aurein-3.2 | GLFDIVKKIAGHIASSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | SNB-75 | CNS cancer | IC50 : 5 μM |
| dbacp01375 | Aurein-3.2 | GLFDIVKKIAGHIASSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | MALME-3M | Melanoma | IC50 : 5 μM |
| dbacp01376 | Aurein-3.2 | GLFDIVKKIAGHIASSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | OVCAR-8 | Ovarian cancer | IC50 : 5 μM |
| dbacp01377 | Aurein-3.2 | GLFDIVKKIAGHIASSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | A498 | Renal cancer | IC50 : 5 μM |
| dbacp01378 | Aurein-3.2 | GLFDIVKKIAGHIASSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | Not found | Prostate cancer | IC50 : 5 μM |
| dbacp01379 | Aurein-3.2 | GLFDIVKKIAGHIASSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | MDA-N | Breast cancer | IC50 : 5 μM |
| dbacp01380 | Aurein-3.2 | GLFDIVKKIAGHIASSI | Southern bell frog | Cell membrane disintegration | Not specified | Not specified | Not specified | LC50 : 10⁻⁵ - 10⁻⁴ M |
| dbacp01381 | Aurein-3.2 | GLFDIVKKIAGHIASSI | Green and golden bell frog | Cell membrane disintegration | Not specified | Not specified | Not specified | LC50 : 10⁻⁵ - 10⁻⁴ M |
| dbacp01384 | Aurein-3.3 [Cleaved into: Aurein-3.3.1] | GLFDIVKKIAGHIVSSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | A549/ATCC | Lung cancer | IC50 : 5 μM |
| dbacp01385 | Aurein-3.3 [Cleaved into: Aurein-3.3.1] | GLFDIVKKIAGHIVSSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | KM12 | Colon cancer | IC50 : 4 - 5 μM |
| dbacp01386 | Aurein-3.3 [Cleaved into: Aurein-3.3.1] | GLFDIVKKIAGHIVSSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | SF-268 | CNS cancer | IC50 : 5 μM |
| dbacp01387 | Aurein-3.3 [Cleaved into: Aurein-3.3.1] | GLFDIVKKIAGHIVSSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | SK-MEL-28 | Melanoma | IC50 : 5 μM |
| dbacp01388 | Aurein-3.3 [Cleaved into: Aurein-3.3.1] | GLFDIVKKIAGHIVSSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | IGR-OV1 | Ovarian cancer | IC50 : 5 μM |
| dbacp01389 | Aurein-3.3 [Cleaved into: Aurein-3.3.1] | GLFDIVKKIAGHIVSSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | SN12C | Renal cancer | IC50 : 5 μM |
| dbacp01390 | Aurein-3.3 [Cleaved into: Aurein-3.3.1] | GLFDIVKKIAGHIVSSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | PC-3 | Prostate cancer | IC50 : 5 μM |
| dbacp01391 | Aurein-3.3 [Cleaved into: Aurein-3.3.1] | GLFDIVKKIAGHIVSSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | MCF7 | Breast cancer | IC50 : 5 μM |
| dbacp01392 | Aurein-3.3 [Cleaved into: Aurein-3.3.1] | GLFDIVKKIAGHIVSSI | Southern bell frog | Cell membrane disintegration | Not specified | Not specified | Not specified | LC50 : 10⁻⁵ - 10⁻⁴ M |
| dbacp01393 | Aurein-3.3.1 | FDIVKKIAGHIVSSI | Southern bell frog | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp01394 | Aurein-4.1 | GLIQTIKEKLKELAGGLVTGIQS | Green and golden bell frog | Cell membrane disintegration | Not specified | Not specified | Not specified | LC50 : 10⁻⁵ - 10⁻⁴ M |
| dbacp01395 | Aurein-4.2 | GLLQTIKEKLKEFAGGVVTGVQS | Southern bell frog | Cell membrane disintegration | Not specified | Not specified | Not specified | LC50 : 10⁻⁵ - 10⁻⁴ M |
| dbacp01396 | Aurein-4.2 | GLLQTIKEKLKEFAGGVVTGVQS | Green and golden bell frog | Cell membrane disintegration | Not specified | Not specified | Not specified | LC50 : 10⁻⁵ - 10⁻⁴ M |
| dbacp01397 | Aurein-4.3 | GLLQTITEKLKEFAGGLVTGVQS | Green and golden bell frog | Cell membrane disintegration | Not specified | Not specified | Not specified | LC50 : 10⁻⁵ - 10⁻⁴ M |
| dbacp01398 | Aurein-4.4 | GLLQTIKEKLKELATGLVIGVQS | Southern bell frog | Cell membrane disintegration | Not specified | Not specified | Not specified | LC50 : 10⁻⁵ - 10⁻⁴ M |
| dbacp01399 | Aurein-4.4 | GLLQTIKEKLKELATGLVIGVQS | Green and golden bell frog | Cell membrane disintegration | Not specified | Not specified | Not specified | LC50 : 10⁻⁵ - 10⁻⁴ M |
| dbacp01400 | Aurein-5.1 | GLLDIVTGLLGNLIVDVLKPKTPAS | Southern bell frog | Cell membrane disintegration | Not specified | Not specified | Not specified | LC50 : 10⁻⁵ - 10⁻⁴ M |
| dbacp01401 | Aurein-5.1 | GLLDIVTGLLGNLIVDVLKPKTPAS | Green and golden bell frog | Cell membrane disintegration | Not specified | Not specified | Not specified | LC50 : 10⁻⁵ - 10⁻⁴ M |
| dbacp01402 | Aurein-5.2 | GLMSSIGKALGGLIVDVLKPKTPAS | Southern bell frog | Cell membrane disintegration | Not specified | Not specified | Not specified | LC50 : 10⁻⁵ - 10⁻⁴ M |
| dbacp01403 | Aurein-5.3 | MAFLKKSLFLVLFLGLVSLSICEQEKREEENQEEDEENEAASEEKRGLMSSIGKALGGLIVDVLKPKTPAS | Green and golden bell frog | Cell membrane disintegration | Not specified | Not specified | Not specified | LC50 : 10⁻⁵ - 10⁻⁴ M |
| dbacp01598 | BF2d | TRSSRAGLQWPVGRVHRLLRKGGC | Synthetic | Cell membrane disintegration | MTT/MTS assay | HeLa | Cervical cancer | At 1 µM 90-100% viablity |
| dbacp01599 | BF2d | TRSSRAGLQWPVGRVHRLLRKGGC | Synthetic | Cell membrane disintegration | MTT/MTS assay | HeLa | Cervical cancer | At 10 µM 90-95% viablity |
| dbacp01600 | BF2d | TRSSRAGLQWPVGRVHRLLRKGGC | Synthetic | Cell membrane disintegration | MTT/MTS assay | HeLa | Cervical cancer | At 100 µM 90-100% viablity |
| dbacp01846 | BMAP-27 | GRFKRFRKKFKKLFKKLSPVIPLLHLG | Cattle | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp01847 | BMAP-27 | GRFKRFRKKFKKLFKKLSPVIPLLHLG | Cattle | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp01848 | BMAP-28 | GGLRSLGRKILRAWKKYGPIIVPIIRIG | Cattle | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp01849 | BMAP-28 | GGLRSLGRKILRAWKKYGPIIVPIIRIG | Peripheral neutrophils; Cattle | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp01924 | Brevinin-1BLa | FLPAIVGAAAKFLPKIFCAISKKC | North America, leopard frog | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp01925 | Brevinin-1BLa | FLPIIAGAAAKVVEKIFCAISKKC | North America, leopard frog | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp01926 | Brevinin-1BLa | FLPIIAGAAAKVVQKIFCAISKKC | North America, leopard frog | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp01927 | Brevinin-1BLa | FLPIIAGIAAKFLPKIFCTISKKC | North America, leopard frog | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp01928 | Brevinin-1BLa | FLPIIAGVAAKVLPKIFCAISKKC | North America, leopard frog | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp01929 | Brevinin-1BLa | FLPVIAGVAANFLPKLFCAISKKC | North America, leopard frog | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp01930 | Brevinin-1BLa | FLPAIVGAAAKFLPKIFCAISKKC | North America, leopard frog | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp01931 | Brevinin-1BLb | FLPIIAGVAAKVLPKIFCAISKKC | North America, leopard frog | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp01932 | Brevinin-1BLc | FLPIIAGIAAKFLPKIFCTISKKC | North America, leopard frog | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp01934 | Brevinin-1BYa | FLPILASLAAKFGPKLFCLVTKKC | Foothill yellow-legged frog, North America | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp01935 | Brevinin-1BYa | FLPILASLAAKFGPKLFCLVTKKC | Skin secretions, the foothill yellow-legged frog, North America | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp01955 | Brevinin-1Ya | FLPVIAGVAANFLPKLFCAISKKC | North America, leopard frog | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp01956 | Brevinin-1Yb | FLPIIAGAAAKVVQKIFCAISKKC | North America, leopard frog | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp01957 | Brevinin-1Yc | FLPIIAGAAAKVVEKIFCAISKKC | North America, leopard frog | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp01986 | Brevinin-ALb | FLPLAVSLAANFLPKLFCKITKKC | Rufous-spotted torrent frog, China, Asia | Cell membrane disintegration | Not specified | HepG2 | Not found | Not found |
| dbacp02113 | C-1 | KWKLFKKIPFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 26 µM |
| dbacp02114 | C-1 | KWKLFKKIPFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | Jurkat | Blood cancer | IC50 : 32 µM |
| dbacp02115 | C-1 | KWKLFKKIPFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | K-562 | Leukemia cancer | IC50 : 31 µM |
| dbacp02116 | C-10 | KWKLFKKIPKFLH | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : <100 µM |
| dbacp02117 | C-10 | KWKLFKKIPKFLH | Ceropin A | Cell membrane disintegration | MTT/MTS assay | Jurkat | Blood cancer | IC50 : <100 µM |
| dbacp02118 | C-10 | KWKLFKKIPKFLH | Ceropin A | Cell membrane disintegration | MTT/MTS assay | K-562 | Leukemia cancer | IC50 : <100 µM |
| dbacp02119 | C-2 | KWKLFKKIPKFLHLAKK | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 38 µM |
| dbacp02120 | C-2 | KWKLFKKIPKFLHLAKK | Ceropin A | Cell membrane disintegration | MTT/MTS assay | Jurkat | Blood cancer | IC50 : 26 µM |
| dbacp02121 | C-2 | KWKLFKKIPKFLHLAKK | Ceropin A | Cell membrane disintegration | MTT/MTS assay | K-562 | Leukemia cancer | IC50 : 23 µM |
| dbacp02122 | C-3 | KWKLFKKIPLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 79 µM |
| dbacp02123 | C-3 | KWKLFKKIPLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | Jurkat | Blood cancer | IC50 : 74 µM |
| dbacp02124 | C-3 | KWKLFKKIPLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | K-562 | Leukemia cancer | IC50 : 62 µM |
| dbacp02125 | C-4 | KWKLFKKIPKFLHLAK | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 54 µM |
| dbacp02126 | C-4 | KWKLFKKIPKFLHLAK | Ceropin A | Cell membrane disintegration | MTT/MTS assay | Jurkat | Blood cancer | IC50 : 31 µM |
| dbacp02127 | C-4 | KWKLFKKIPKFLHLAK | Ceropin A | Cell membrane disintegration | MTT/MTS assay | K-562 | Leukemia cancer | IC50 : 25 µM |
| dbacp02128 | C-5 | KWKLFKKIPHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 100 µM |
| dbacp02129 | C-5 | KWKLFKKIPHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | Jurkat | Blood cancer | IC50 : 81 µM |
| dbacp02130 | C-5 | KWKLFKKIPHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | K-562 | Leukemia cancer | IC50 : 67 µM |
| dbacp02131 | C-6 | KWKLFKKIPKFLHLA | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 47 µM |
| dbacp02132 | C-6 | KWKLFKKIPKFLHLA | Ceropin A | Cell membrane disintegration | MTT/MTS assay | Jurkat | Blood cancer | IC50 : 21 µM |
| dbacp02133 | C-6 | KWKLFKKIPKFLHLA | Ceropin A | Cell membrane disintegration | MTT/MTS assay | K-562 | Leukemia cancer | IC50 : 27 µM |
| dbacp02134 | C-7 | KWKLFKKIPLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : <100 µM |
| dbacp02135 | C-7 | KWKLFKKIPLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | Jurkat | Blood cancer | IC50 : <100 µM |
| dbacp02136 | C-7 | KWKLFKKIPLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | K-562 | Leukemia cancer | IC50 : <100 µM |
| dbacp02137 | C-8 | KWKLFKKIPKFLHL | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 83 µM |
| dbacp02138 | C-8 | KWKLFKKIPKFLHL | Ceropin A | Cell membrane disintegration | MTT/MTS assay | Jurkat | Blood cancer | IC50 : 54 µM |
| dbacp02139 | C-8 | KWKLFKKIPKFLHL | Ceropin A | Cell membrane disintegration | MTT/MTS assay | K-562 | Leukemia cancer | IC50 : 30 µM |
| dbacp02140 | C-9 | KWKLFKKIPLKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : <100 µM |
| dbacp02141 | C-9 | KWKLFKKIPLKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | Jurkat | Blood cancer | IC50 : <100 µM |
| dbacp02142 | C-9 | KWKLFKKIPLKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | K-562 | Leukemia cancer | IC50 : <100 µM |
| dbacp02231 | CA-MA | KWKLFKKIGIGKFLHSAKKF | Ceropin-African clawed frog hybrid peptides | Cell membrane disintegration | MTT/MTS assay | K-562 | Leukemia cancer | IC50 : 65 µM |
| dbacp02232 | CA-MA | KWKLFKKIGIGKFLHSAKKF | Ceropin-African clawed frog hybrid peptides | Cell membrane disintegration | MTT/MTS assay | A-549 | Lung cancer | IC50 : 60 µM |
| dbacp02233 | CA-MA | KWKLFKKIGIGKFLHSAKKF | Ceropin-African clawed frog hybrid peptides | Cell membrane disintegration | MTT/MTS assay | Jurkat | Blood cancer | IC50 : 30 µM |
| dbacp02234 | CA-MA | KWKLFKKIGIGKFLHSAKKF | Ceropin-African clawed frog hybrid peptides | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 44 µM |
| dbacp02238 | CA-MA-P | KWKLFKKIPKFLHSAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 20 µM |
| dbacp02239 | CA-MA-P | KWKLFKKIPKFLHSAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | Jurkat | Blood cancer | IC50 : 20 µM |
| dbacp02240 | CA-MA-P | KWKLFKKIPKFLHSAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | K-562 | Leukemia cancer | IC50 : 25 µM |
| dbacp02241 | CA-MA1 | KWKLFKKIKFLHSAKKF | Ceropin-African clawed frog hybrid peptides | Cell membrane disintegration | MTT/MTS assay | K-562 | Leukemia cancer | IC50 : 85.3 µM |
| dbacp02242 | CA-MA1 | KWKLFKKIKFLHSAKKF | Ceropin-African clawed frog hybrid peptides | Cell membrane disintegration | MTT/MTS assay | A-549 | Lung cancer | IC50 : 100 µM |
| dbacp02243 | CA-MA1 | KWKLFKKIKFLHSAKKF | Ceropin-African clawed frog hybrid peptides | Cell membrane disintegration | MTT/MTS assay | Jurkat | Blood cancer | IC50 : 65 µM |
| dbacp02244 | CA-MA1 | KWKLFKKIKFLHSAKKF | Ceropin-African clawed frog hybrid peptides | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 100 µM |
| dbacp02245 | CA-MA2 | KWKLFKKIPKFLHSAKKF | Ceropin-African clawed frog hybrid peptides | Cell membrane disintegration | MTT/MTS assay | K-562 | Leukemia cancer | IC50 : 35.1 µM |
| dbacp02246 | CA-MA2 | KWKLFKKIPKFLHSAKKF | Ceropin-African clawed frog hybrid peptides | Cell membrane disintegration | MTT/MTS assay | A-549 | Lung cancer | IC50 : 25 µM |
| dbacp02247 | CA-MA2 | KWKLFKKIPKFLHSAKKF | Ceropin-African clawed frog hybrid peptides | Cell membrane disintegration | MTT/MTS assay | Jurkat | Blood cancer | IC50 : 20 µM |
| dbacp02248 | CA-MA2 | KWKLFKKIPKFLHSAKKF | Ceropin-African clawed frog hybrid peptides | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 28 µM |
| dbacp02249 | CA-MA3 | KWKLFKKIGPGKFLHSAKKF | Ceropin-African clawed frog hybrid peptides | Cell membrane disintegration | MTT/MTS assay | K-562 | Leukemia cancer | IC50 : >100 µM |
| dbacp02250 | CA-MA3 | KWKLFKKIGPGKFLHSAKKF | Ceropin-African clawed frog hybrid peptides | Cell membrane disintegration | MTT/MTS assay | A-549 | Lung cancer | IC50 : >100 µM |
| dbacp02251 | CA-MA3 | KWKLFKKIGPGKFLHSAKKF | Ceropin-African clawed frog hybrid peptides | Cell membrane disintegration | MTT/MTS assay | Jurkat | Blood cancer | IC50 : 75 µM |
| dbacp02252 | CA-MA3 | KWKLFKKIGPGKFLHSAKKF | Ceropin-African clawed frog hybrid peptides | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : >100 µM |
| dbacp02256 | Caerin 1.1 | GLLSVLGSVAKHVLPHVVPVIAEHL | Australian green tree frog | Cell membrane disintegration | Not specified | Not found | Lung cancer | Not found |
| dbacp02257 | Caerin 1.1 | GLLSVLGSVAKHVLPHVVPVIAEHL | Australian green tree frog | Cell membrane disintegration | Not specified | Not found | Lung cancer | Not found |
| dbacp02258 | Caerin 1.10 | GLLSVLGSVAKHVLPHVVPVIAEKL | Magnificent treefrog, Australia | Cell membrane disintegration | Not specified | Not found | Lung cancer | Not found |
| dbacp02259 | Caerin 1.10 | GLLSVLGSVAKHVLPHVVPVIAEKL | Magnificent treefrog, Australia | Cell membrane disintegration | Not specified | Not found | Lung cancer | Not found |
| dbacp02260 | Caerin 1.3 | GLLSVLGSVAQHVLPHVVPVIAEHL | Common green treefrog, Australian frog | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp02261 | Caerin 1.5 | GLLSVLGSVVKHVIPHVVPVIAEHL | Common green treefrog, Australian frog | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp02262 | Caerin 1.6 | GLFSVLGAVAKHVLPHVVPVIAEK | Blue-thighed frog, Australia | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp02263 | Caerin 1.6 | GLFSVLGAVAKHVLPHVVPVIAEK | Orange thighed treefrog, Australia | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp02264 | Caerin 1.7 | GLFKVLGSVAKHLLPHVAPVIAEK | Orange thighed treefrog, Australia | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp02265 | Caerin 1.7 | GLFKVLGSVAKHLLPHVAPVIAEK | Orange thighed treefrog, Australia | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp02266 | Caerin 1.8 | GLFKVLGSVAKHLLPHVVPVIAEK | Blue-thighed frog, Australia | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp02267 | Caerin 1.8 | GLFKVLGSVAKHLLPHVVPVIAEK | Blue-thighed frog, Australia | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp02268 | Caerin 1.9 | GLFGVLGSIAKHVLPHVVPVIAEK | Red-eyed tree frog, Australia | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp02269 | Caerin 1.9 | GLFGVLGSIAKHVLPHVVPVIAEK | Blue-thighed frog, Australia | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp02313 | Cathelicidin-BF | KFFRKLKKSVKKRAKEFFKKPRVIGVSIPF | Venom, banded krait | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp02321 | CB | KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL | Synthetic | Cell membrane disintegration | Not specified | Ags | Gastric cancer | Not found |
| dbacp02323 | Cecropin 2 | GWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLK | The Medfly, also housefly | Cell membrane disintegration | Not specified | Not found | Leukemia cancer | Not found |
| dbacp02325 | Cecropin 2 | GWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLK | The Medfly, also housefly | Cell membrane disintegration | Not specified | Not found | Leukemia cancer | Not found |
| dbacp02343 | Cecropin A | KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK | Giant silk moth, cecropia moth | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp02465 | Chaxapeptin | GFGSKPLDSFGLNFF | Spore-forming, Gram-positive bacteria,"gifted" actinomycete strain C58; extremophile | Cell membrane disintegration | Cell invasion assay | A549 | Lung cancer | MIC : 50 μM |
| dbacp02482 | Chrysophsin-1 | FFGWLIKGAIHAGKAIHGLIHRRRH | Red sea bream, The pyloric caeca and gills | Cell membrane disintegration | Not specified | Not found | Breast cancer | Not found |
| dbacp02486 | Chrysophsin-1 | FFGWLIKGAIHAGKAIHGLIHRRRH | The pyloric caeca and gills; Red sea bream | Cell membrane disintegration | Not specified | Not found | Breast cancer | Not found |
| dbacp02497 | Citropin 1.1 | GLFDVIKKVASVIGGL | Skin secretion, Australian blue mountains tree frog | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp02508 | Citropin 1.2 | GLFDIIKKVASVVGGL | Australian blue mountains tree frog | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp02509 | Citropin 1.2 | GLFDIIKKVASVVGGL | Australian blue mountains tree frog | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp02510 | Citropin 1.3 | GLFDIIKKVASVIGGL | Australian blue mountains tree frog | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp02511 | Citropin 1.3 | GLFDIIKKVASVIGGL | Australian blue mountains tree frog | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp02532 | Cn-AMP1 | SVAGRAQGM | Green coconut water | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp02533 | Cn-AMP2 | TESYFVFSVGM | Green coconut water | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp02550 | CPF-ST3 | GLLGPLLKIAAKVGSNLL | Diploid clawed frog, Western clawed frog,Africa | Cell membrane disintegration | Not specified | Not found | Skin cancer | Not found |
| dbacp02551 | CPF-ST3 | GLLGPLLKIAAKVGSNLL | Diploid clawed frog, Western clawed frog,Africa | Cell membrane disintegration | Not specified | Not found | Skin cancer | Not found |
| dbacp02574 | Crotamine | YKQCHKKGGHCFPKEKICLPPSSDFGKMDCRWRWKCCKKGSG | rattlesnake venom,South American rattlesnake | Cell membrane disintegration | Not specified | Not found | Breast cancer | Not found |
| dbacp02576 | Crotamine | YKQCHKKGGHCFPKEKICLPPSSDFGKMDCRWRWKCCKKGSG | Venom,South American rattlesnake | Cell membrane disintegration | Not specified | Not found | Breast cancer | Not found |
| dbacp02581 | CSP-FT | FTPGGNTYAGQP | Not found | Cell membrane disintegration | Not specified | C-33A | Human Cervical cancer | Not found |
| dbacp02582 | CSP-GD | GDALFSVPLEVY | Not found | Cell membrane disintegration | Not specified | SiH | Human Cervical cancer | Not found |
| dbacp02583 | CSP-KQ | KQNLAEG | Not found | Cell membrane disintegration | Not specified | C-33A | Human Cervical cancer | Not found |
| dbacp02584 | CSP-SI | SIDDQRDVAEFA | Not found | Cell membrane disintegration | Not specified | C-33A | Human Cervical cancer | Not found |
| dbacp02585 | CSP-TL | TLHQPPSSANWI | Not found | Cell membrane disintegration | Not specified | SiH | Human Cervical cancer | Not found |
| dbacp02600 | Cycloviolacin O2 | GIPCGESCVWIPCISSAIGCSCKSKVCYRN | Not found | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp02601 | Cycloviolacin O2 | GIPCGESCVWIPCISSAIGCSCKSKVCYRN | Not found | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp02662 | Dermaseptin-L1 | GLWSKIKEAAKAAGKAALNAVTGLVNQGDQPS | Lemur leaf frog, South America | Cell membrane disintegration | Not specified | Not found | Colorectal cancer | Not found |
| dbacp02663 | Dermaseptin-L1 | GLWSKIKEAAKAAGKAALNAVTGLVNQGDQPS | Lemur leaf frog, South America | Cell membrane disintegration | Not specified | Not found | Colorectal cancer | Not found |
| dbacp02664 | Dermaseptin-L1 (DRS-L1) | GLWSKIKEAAKAAGKAALNAVTGLVNQGDQPS | Lemur leaf frog | Cell membrane disintegration | Not specified | Not found | Colorectal cancer | Not found |
| dbacp02665 | Dermaseptin-L1 (DRS-L1) | GLWSKIKEAAKAAGKAALNAVTGLVNQGDQPS | Lemur leaf frog | Cell membrane disintegration | Not specified | Not found | Colorectal cancer | Not found |
| dbacp02748 | Di-PST13-RK-C | KKKFPWWWPFKKKCKKKFPWWWPFKKKC | Derivative of tritrpticin | Cell membrane disintegration | MTT/MTS assay | A-549 | Lung cancer | IC50 : 17 µg/ml |
| dbacp02749 | Di-PST13-RK-C | KKKFPWWWPFKKKCKKKFPWWWPFKKKC | Derivative of tritrpticin | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 17 µg/ml |
| dbacp02750 | Di-PST13-RK-K | KKKFPWWWPFKKKKKKFPWWWPFKKKK | Derivative of tritrpticin | Cell membrane disintegration | MTT/MTS assay | A-549 | Lung cancer | IC50 : 15 µg/ml |
| dbacp02751 | Di-PST13-RK-K | KKKFPWWWPFKKKKKKFPWWWPFKKKK | Derivative of tritrpticin | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 10 µg/ml |
| dbacp02783 | dLL-37(17-32)c | FKRiVQRiKDFlRNLV | LL-37, a series of peptide fragments | Cell membrane disintegration | MTT/MTS assay | KBv | Tumor | Not found |
| dbacp02784 | dLL-37(17-32)c | FKRIVQRIKDFLRNLV | LL-37, a series of peptide fragments | Cell membrane disintegration | MTT/MTS assay | KBv | Oral cancer | Not found |
| dbacp02785 | dLL-37(17-32)c | FKRIVQRIKDFLRNLV | LL-37, a series of peptide fragments | Cell membrane disintegration | MTT/MTS assay | HBMEC | Prostate cancer | Not found |
| dbacp02813 | Drosophila Antennapedia homodomain PFV | CALNNPFVYLI | Fruit fly homodomain PFV | Cell membrane disintegration | SPR assay | B16 | Mouse melanoma | Not found |
| dbacp02814 | Drosophila Antennapedia homodomain PFV | CALNNPFVYLI | Fruit fly homodomain PFV | Cell membrane disintegration | SPR assay | A549 | Human lung adenocarcinoma | Not found |
| dbacp02823 | Dybowskin-2 | FLIGMTQGLICLITRKC | Dybowski's frog, Chinese brown frog, Asia | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp02824 | Dybowskin-2 | FLIGMTQGLICLITRKC | Dybowski's frog, Chinese brown frog, Asia | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp02825 | Dybowskin-3 | GLFDVVKGVLKGVGKNVAGSLLEQLKCKLSGGC | Dybowski's frog, Chinese brown frog, Asia | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp02842 | EP5-1 | ACSAG | Redworms, brandling worms, "tiger worms" and red wiggler worms | Cell membrane disintegration | Not specified | Not found | Fibrosarcoma | Not found |
| dbacp03122 | Gomesin | ECRRLCYKQRCVTYCRGR | Hemocytes, Tarantula spider sp. | Cell membrane disintegration | Not specified | Not found | Breast cancer | Not found |
| dbacp03123 | Gomesin | QCRRLCYKQRCVTYCRGR | Hemocytes, Tarantula spider sp. | Cell membrane disintegration | Not specified | Not found | Breast cancer | Not found |
| dbacp03170 | Gramicidin A | VGALAVVVWLWLWLW | Soil bacterium | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp03273 | Halictine 1 | GMWSKILGHLIR | Venom, the eusocial bee | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp03275 | Halictine 1 | GMWSKILGHLIR | Venom, the eusocial bee | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp03276 | Halictine 2 | GKWMSLLKHILK | Venom, the eusocial bee | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp03278 | Halictine 2 | GKWMSLLKHILK | Venom, the eusocial bee | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp03281 | hBD-1 | DHYNCVSSGGQCLYSACPIFTKIQGTCYRGKAKCCK | Keratinocytes; skin; platelets; Human | Cell membrane disintegration | Not specified | Not found | Fibrosarcoma | Not found |
| dbacp03282 | hBD-1 | DHYNCVSSGGQCLYSACPIFTKIQGTCYRGKAKCCK | Airway, hemofiltrates, urine, kidney; keratinocytes; skin; platelets; oral saliva; milk, mammary gland epithelium, colonic mucosa, Human | Cell membrane disintegration | Not specified | Not found | Fibrosarcoma | Not found |
| dbacp03290 | HECI | TVLRGCWTFSFPPKPCI | Hylarana erythraea | Cell membrane disintegration | MTT anti-proliferation assay | H157 | Lung cancer | MIC : 1µM |
| dbacp03291 | HECI | TVLRGCWTFSFPPKPCI | Hylarana erythraea | Cell membrane disintegration | MTT anti-proliferation assay | PC-3 | Prostate cancer | MIC : 1µM |
| dbacp03292 | HECI | TVLRGCWTFSFPPKPCI | Hylarana erythraea | Cell membrane disintegration | MTT anti-proliferation assay | MCF-7 | Breast cancer | MIC : 1µM |
| dbacp03294 | hepcidin TH1-5 | GIKCRFCCGCCTPGICGVCCRF | Mozambique tilapia | Cell membrane disintegration | Not specified | Not found | Colorectal cancer | Not found |
| dbacp03295 | hepcidin TH1-5 | GIKCRFCCGCCTPGICGVCCRF | Mozambique tilapia | Cell membrane disintegration | Not specified | Not found | Colorectal cancer | Not found |
| dbacp03296 | hepcidin TH2-3 | QSHLSLCRWCCNCCRSNKGC | Mozambique tilapia | Cell membrane disintegration | Not specified | Not found | Colorectal cancer | Not found |
| dbacp03316 | HNP-1 | ACYCRIPACIAGERRYGTCIYQGRLWAFCC | Human | Cell membrane disintegration | Not specified | Not found | Fibrosarcoma | Not found |
| dbacp03317 | HNP-2 | CYCRIPACIAGERRYGTCIYQGRLWAFCC | Human | Cell membrane disintegration | Not specified | Not found | Fibrosarcoma | Not found |
| dbacp03318 | HNP-3 | DCYCRIPACIAGERRYGTCIYQGRLWAFCC | Human | Cell membrane disintegration | Not specified | Not found | Fibrosarcoma | Not found |
| dbacp03336 | Human neutrophil peptide-1 | ACYCRIPACIAGERRYGTCIYQGRLWAFCC | Neutrophils; natural killer cells, monocytes; airway, saliva; Human | Cell membrane disintegration | Not specified | Not found | Fibrosarcoma | Not found |
| dbacp03337 | Human neutrophil peptide-2 | CYCRIPACIAGERRYGTCIYQGRLWAFCC | Neutrophils; natural killer cells, monocytes; airway, saliva; Human | Cell membrane disintegration | Not specified | Not found | Fibrosarcoma | Not found |
| dbacp03338 | Human neutrophil peptide-3 | DCYCRIPACIAGERRYGTCIYQGRLWAFCC | Neutrophils; natural killer cells, monocytes; airway, saliva; Human | Cell membrane disintegration | Not specified | Not found | Fibrosarcoma | Not found |
| dbacp03380 | Imcroporin | FFSLLPSLIGGLVSAIK | Lesser brown scorpion | Cell membrane disintegration | MTT assay | EK293T | Not found | MIC : 50 µg/ml |
| dbacp03381 | Imcroporin | FFSLLPSLIGGLVSAIK | Lesser brown scorpion | Cell membrane disintegration | MTT assay | SMMC-7721 | Not found | MIC : 100 µg/ml |
| dbacp03549 | L1 | PEWFKCRRWQWRMKKLGA | Lactoferrin | Cell membrane disintegration | MTT/MTS assay | Meth A | Skin cancer | IC50 : > 404 µM |
| dbacp03550 | L1 | PEWFKCRRWQWRMKKLGA | Lactoferrin | Cell membrane disintegration | MTT/MTS assay | MT-1 | Breast cancer | IC50 : > 404 µM |
| dbacp03551 | L1 | PEWFKCRRWQWRMKKLGA | Lactoferrin | Cell membrane disintegration | MTT/MTS assay | HT-29 | Colon cancer | IC50 : > 404 µM |
| dbacp03552 | L10 | PAARKAFRWAWRMLKKAA | Lactoferrin | Cell membrane disintegration | MTT/MTS assay | Meth A | Skin cancer | IC50 : 24 µM |
| dbacp03553 | L10 | PAARKAFRWAWRMLKKAA | Lactoferrin | Cell membrane disintegration | MTT/MTS assay | MT-1 | Breast cancer | IC50 : 20 µM |
| dbacp03554 | L10 | PAARKAFRWAWRMLKKAA | Lactoferrin | Cell membrane disintegration | MTT/MTS assay | HT-29 | Colon cancer | IC50 : 35 µM |
| dbacp03555 | L11 | PAARKAARWAWRMLKKGA | Lactoferrin | Cell membrane disintegration | MTT/MTS assay | Meth A | Skin cancer | IC50 : 116 µM |
| dbacp03556 | L11 | PAARKAARWAWRMLKKGA | Lactoferrin | Cell membrane disintegration | MTT/MTS assay | MT-1 | Breast cancer | IC50 : 75 µM |
| dbacp03557 | L11 | PAARKAARWAWRMLKKGA | Lactoferrin | Cell membrane disintegration | MTT/MTS assay | HT-29 | Colon cancer | IC50 : 248 µM |
| dbacp03558 | L12 | PAWRKAFRWAKRMLKKAA | Lactoferrin | Cell membrane disintegration | MTT/MTS assay | Meth A | Skin cancer | IC50 : 7.9 µM |
| dbacp03559 | L12 | PAWRKAFRWAKRMLKKAA | Lactoferrin | Cell membrane disintegration | MTT/MTS assay | MT-1 | Breast cancer | IC50 : 10 µM |
| dbacp03560 | L12 | PAWRKAFRWAKRMLKKAA | Lactoferrin | Cell membrane disintegration | MTT/MTS assay | HT-29 | Colon cancer | IC50 : 25 µM |
| dbacp03561 | L13 | PAWRKAFRKAWRMLKKAA | Lactoferrin | Cell membrane disintegration | MTT/MTS assay | Meth A | Skin cancer | IC50 : 14 µM |
| dbacp03562 | L13 | PAWRKAFRKAWRMLKKAA | Lactoferrin | Cell membrane disintegration | MTT/MTS assay | MT-1 | Breast cancer | IC50 : 12 µM |
| dbacp03563 | L13 | PAWRKAFRKAWRMLKKAA | Lactoferrin | Cell membrane disintegration | MTT/MTS assay | HT-29 | Colon cancer | IC50 : 29 µM |
| dbacp03564 | L14 | PAWRKARRWAWRMKKLAA | Lactoferrin | Cell membrane disintegration | MTT/MTS assay | Meth A | Skin cancer | IC50 : 125 µM |
| dbacp03565 | L14 | PAWRKARRWAWRMKKLAA | Lactoferrin | Cell membrane disintegration | MTT/MTS assay | MT-1 | Breast cancer | IC50 : 141 µM |
| dbacp03566 | L14 | PAWRKARRWAWRMKKLAA | Lactoferrin | Cell membrane disintegration | MTT/MTS assay | HT-29 | Colon cancer | IC50 : 423 µM |
| dbacp03567 | L15 | PAWRKARRWARRMKKLAA | Lactoferrin | Cell membrane disintegration | MTT/MTS assay | Meth A | Skin cancer | IC50 : 87 µM |
| dbacp03568 | L15 | PAWRKARRWARRMKKLAA | Lactoferrin | Cell membrane disintegration | MTT/MTS assay | MT-1 | Breast cancer | IC50 : 92 µM |
| dbacp03569 | L15 | PAWRKARRWARRMKKLAA | Lactoferrin | Cell membrane disintegration | MTT/MTS assay | HT-29 | Colon cancer | IC50 : 178 µM |
| dbacp03586 | L2 | PAWFKARRWAWRMKKLAA | Lactoferrin | Cell membrane disintegration | MTT/MTS assay | Meth A | Skin cancer | IC50 : 144 µM |
| dbacp03587 | L2 | PAWFKARRWAWRMKKLAA | Lactoferrin | Cell membrane disintegration | MTT/MTS assay | MT-1 | Breast cancer | IC50 : >254 µM |
| dbacp03588 | L2 | PAWFKARRWAWRMKKLAA | Lactoferrin | Cell membrane disintegration | MTT/MTS assay | HT-29 | Colon cancer | IC50 : >440 µM |
| dbacp03597 | L3 | PAWRKAFRWAWRMKKLAA | Lactoferrin | Cell membrane disintegration | MTT/MTS assay | Meth A | Skin cancer | IC50 : 32 µM |
| dbacp03598 | L3 | PAWRKAFRWAWRMKKLAA | Lactoferrin | Cell membrane disintegration | MTT/MTS assay | MT-1 | Breast cancer | IC50 : 18 µM |
| dbacp03599 | L3 | PAWRKAFRWAWRMKKLAA | Lactoferrin | Cell membrane disintegration | MTT/MTS assay | HT-29 | Colon cancer | IC50 : 141 µM |
| dbacp03604 | L4 | PAWFKARRWAWRMLKKAA | Lactoferrin | Cell membrane disintegration | MTT/MTS assay | Meth A | Skin cancer | IC50 : 31 µM |
| dbacp03605 | L4 | PAWFKARRWAWRMLKKAA | Lactoferrin | Cell membrane disintegration | MTT/MTS assay | MT-1 | Breast cancer | IC50 : 16 µM |
| dbacp03606 | L4 | PAWFKARRWAWRMLKKAA | Lactoferrin | Cell membrane disintegration | MTT/MTS assay | HT-29 | Colon cancer | IC50 : 57 µM |
| dbacp03607 | L5 | PAWRKAFRWAWRMLKKAA | Lactoferrin | Cell membrane disintegration | MTT/MTS assay | Meth A | Skin cancer | IC50 : 6.6 µM |
| dbacp03608 | L5 | PAWRKAFRWAWRMLKKAA | Lactoferrin | Cell membrane disintegration | MTT/MTS assay | MT-1 | Breast cancer | IC50 : 8 µM |
| dbacp03609 | L5 | PAWRKAFRWAWRMLKKAA | Lactoferrin | Cell membrane disintegration | MTT/MTS assay | HT-29 | Colon cancer | IC50 : 14 µM |
| dbacp03610 | L6 | PAWRKAFRWAARMLKKAA | Lactoferrin | Cell membrane disintegration | MTT/MTS assay | Meth A | Skin cancer | IC50 : 11 µM |
| dbacp03611 | L6 | PAWRKAFRWAARMLKKAA | Lactoferrin | Cell membrane disintegration | MTT/MTS assay | MT-1 | Breast cancer | IC50 : 12 µM |
| dbacp03612 | L6 | PAWRKAFRWAARMLKKAA | Lactoferrin | Cell membrane disintegration | MTT/MTS assay | HT-29 | Colon cancer | IC50 : 15 µM |
| dbacp03629 | L7 | PAWRKAFRAAWRMLKKAA | Lactoferrin | Cell membrane disintegration | MTT/MTS assay | Meth A | Skin cancer | IC50 : 16 µM |
| dbacp03630 | L7 | PAWRKAFRAAWRMLKKAA | Lactoferrin | Cell membrane disintegration | MTT/MTS assay | MT-1 | Breast cancer | IC50 : 11 µM |
| dbacp03631 | L7 | PAWRKAFRAAWRMLKKAA | Lactoferrin | Cell membrane disintegration | MTT/MTS assay | HT-29 | Colon cancer | IC50 : 16 µM |
| dbacp03632 | L8 | PAWAKAFRAAARMKLKAA | Lactoferrin | Cell membrane disintegration | MTT/MTS assay | Meth A | Skin cancer | IC50 : 110 µM |
| dbacp03633 | L8 | PAWAKAFRAAARMKLKAA | Lactoferrin | Cell membrane disintegration | MTT/MTS assay | MT-1 | Breast cancer | IC50 : 87 µM |
| dbacp03634 | L8 | PAWAKAFRAAARMKLKAA | Lactoferrin | Cell membrane disintegration | MTT/MTS assay | HT-29 | Colon cancer | IC50 : 180 µM |
| dbacp03635 | L9 | PAWRKAARWAWRMLKKAA | Lactoferrin | Cell membrane disintegration | MTT/MTS assay | Meth A | Skin cancer | IC50 : 35 µM |
| dbacp03636 | L9 | PAWRKAARWAWRMLKKAA | Lactoferrin | Cell membrane disintegration | MTT/MTS assay | MT-1 | Breast cancer | IC50 :32 µM |
| dbacp03637 | L9 | PAWRKAARWAWRMLKKAA | Lactoferrin | Cell membrane disintegration | MTT/MTS assay | HT-29 | Colon cancer | IC50 : 52 µM |
| dbacp03675 | Lasioglossin LL-I | VNWKKVLGKIIKVAK | The Eusocial Bee, Broad-faced Furrow Bee | Cell membrane disintegration | Not specified | Not found | Not found | LC50 : > 200 µM |
| dbacp03678 | Lasioglossin LL-II | VNWKKILGKIIKVAK | The Eusocial Bee, Broad-faced Furrow Bee | Cell membrane disintegration | Not specified | Not found | Not found | LC50 : > 200 µM |
| dbacp03681 | Lasioglossin LL-III | VNWKKILGKIIKVVK | Broad-faced Furrow Bee | Cell membrane disintegration | XTT test | L1210 | Not found | IC50 : 4.7 μM |
| dbacp03682 | Lasioglossin LL-III | VNWKKILGKIIKVVK | Broad-faced Furrow Bee | Cell membrane disintegration | XTT test | CCRF-CEM T | Not found | IC50 : 5.0 μM |
| dbacp03683 | Lasioglossin LL-III | VNWKKILGKIIKVVK | Broad-faced Furrow Bee | Cell membrane disintegration | XTT test | HL-60 | Not found | IC50 : 4.5 μM |
| dbacp03684 | Lasioglossin LL-III | VNWKKILGKIIKVVK | Broad-faced Furrow Bee | Cell membrane disintegration | XTT test | HeLa S3 | Not found | IC50 : 8.4 μM |
| dbacp03685 | Lasioglossin LL-III | VNWKKILGKIIKVVK | Broad-faced Furrow Bee | Cell membrane disintegration | MTT test | HeLa S3 | Not found | IC50 : 5.0 μM |
| dbacp03686 | Lasioglossin LL-III | VNWKKILGKIIKVVK | Broad-faced Furrow Bee | Cell membrane disintegration | MTT test | PC12 | Not found | IC50 : 10.0 μM |
| dbacp03687 | Lasioglossin LL-III | VNWKKILGKIIKVVK | Broad-faced Furrow Bee | Cell membrane disintegration | MTT test | SW480 | Not found | IC50 : 15.0 μM |
| dbacp03708 | Laterosporulin10 | ACVNQCPDAIDRFIVKDKGCHGVEKKYYKQVYVACMNGQHLYCRTEWGGPCQL | Spore-forming, rod-shaped bacterium strain SKDU10 | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp03730 | LfcinB | FKCRRWQWRMKK | Bovine lactoferrin (Lf-B) | Cell membrane disintegration; Regulation of immune response; Apoptosis | MTT/MTS assay | HT-29 | Colon cancer | IC50 : > 160 µM |
| dbacp03731 | LfcinB | FKCRRWQWRMKK | Bovine lactoferrin (Lf-B) | Cell membrane disintegration; Regulation of immune response; Apoptosis | MTT/MTS assay | MT-1 | Breast cancer | IC50 : > 160 µM |
| dbacp03732 | LfcinB | FKCRRWQWRMKK | Bovine lactoferrin (Lf-B) | Cell membrane disintegration; Regulation of immune response; Apoptosis | MTT/MTS assay | Kelly | Brain tumor | IC50 : 141 ± 3 µM |
| dbacp03733 | LfcinB | FKCRRWQWRMKK | Bovine lactoferrin (Lf-B) | Cell membrane disintegration; Regulation of immune response; Apoptosis | MTT/MTS assay | FEMX | Skin cancer | IC50 : 40 ± 7 µM |
| dbacp03734 | LfcinB | FKCRRWQWRMKK | Bovine lactoferrin (Lf-B) | Cell membrane disintegration; Regulation of immune response; Apoptosis | MTT/MTS assay | HT-29 | Colon cancer | IC50 : 148 ± 8 µM |
| dbacp03735 | LfcinB | FKCRRWQWRMKK | Bovine lactoferrin (Lf-B) | Cell membrane disintegration; Regulation of immune response; Apoptosis | MTT/MTS assay | KMS-5 | Skin cancer | IC50 : 38 µM |
| dbacp03736 | LfcinB | FKCRRWQWRMKK | Bovine lactoferrin (Lf-B) | Cell membrane disintegration; Regulation of immune response; Apoptosis | MTT/MTS assay | U-266 | Lymphoma cancer | IC50 : 55 µM |
| dbacp03737 | LfcinB | FKCRRWQWRMKK | Bovine lactoferrin (Lf-B) | Cell membrane disintegration; Regulation of immune response; Apoptosis | MTT/MTS assay | KMM-1 | Skin cancer | IC50 : 57 µM |
| dbacp03738 | LfcinB | FKCRRWQWRMKK | Bovine lactoferrin (Lf-B) | Cell membrane disintegration; Regulation of immune response; Apoptosis | MTT/MTS assay | Sudhl-4 | Skin cancer | IC50 : 16 µM |
| dbacp03739 | LfcinB | FKCRRWQWRMKK | Bovine lactoferrin (Lf-B) | Cell membrane disintegration; Regulation of immune response; Apoptosis | MTT/MTS assay | Raji | Lymphoma cancer | IC50 : 13 µM |
| dbacp03740 | LfcinB | FKCRRWQWRMKK | Bovine lactoferrin (Lf-B) | Cell membrane disintegration; Regulation of immune response; Apoptosis | MTT/MTS assay | Ramos | Lymphoma cancer | IC50 : 10 µM |
| dbacp04130 | LK1 (Temporin-1CEa Analog peptide) | FVDLKKIANIINSIFKK | Synthetic construct | Cell membrane disintegration | MTT-assay | MCF-7 | Breast cancer | IC50 : 20.97 µM |
| dbacp04131 | LK1 (Temporin-1CEa Analog peptide) | FVDLKKIANIINSIFKK | Synthetic construct | Cell membrane disintegration | MTT-assay | Bcap-37 | Breast cancer | IC50 : 18.7 µM |
| dbacp04132 | LK1 (Temporin-1CEa Analog peptide) | FVDLKKIANIINSIFKK | Synthetic construct | Cell membrane disintegration | MTT-assay | MDA-MB-231 | Breast cancer | IC50 : 66.4µM |
| dbacp04133 | LK2(5) (Temporin-1CEa Analog peptide) | FKDLKKIANIINSIFKK | Synthetic construct | Cell membrane disintegration | MTT-assay | MCF-7 | Breast cancer | IC50 : 44.7 µM |
| dbacp04134 | LK2(5) (Temporin-1CEa Analog peptide) | FKDLKKIANIINSIFKK | Synthetic construct | Cell membrane disintegration | MTT-assay | Bcap-37 | Breast cancer | IC50 : 83.49 µM |
| dbacp04135 | LK2(5) (Temporin-1CEa Analog peptide) | FKDLKKIANIINSIFKK | Synthetic construct | Cell membrane disintegration | MTT-assay | MDA-MB-231 | Breast cancer | IC50 : 894.7 µM |
| dbacp04136 | LK2(6) (Temporin-1CEa Analog peptide) | FVKLKKIANIINSIFKK | Synthetic construct | Cell membrane disintegration | MTT-assay | MCF-7 | Breast cancer | IC50 : 15.54 µM |
| dbacp04137 | LK2(6) (Temporin-1CEa Analog peptide) | FVKLKKIANIINSIFKK | Synthetic construct | Cell membrane disintegration | MTT-assay | Bcap-37 | Breast cancer | IC50 : 18.9 µM |
| dbacp04138 | LK2(6) (Temporin-1CEa Analog peptide) | FVKLKKIANIINSIFKK | Synthetic construct | Cell membrane disintegration | MTT-assay | MDA-MB-231 | Breast cancer | IC50 : 85.41 µM |
| dbacp04139 | LK2(6)A(L) (Temporin-1CEa Analog peptide) | FVKLKKILNIINSIFKK | Synthetic construct | Cell membrane disintegration | MTT-assay | MCF-7 | Breast cancer | IC50 : 9.01 µM |
| dbacp04140 | LK2(6)A(L) (Temporin-1CEa Analog peptide) | FVKLKKILNIINSIFKK | Synthetic construct | Cell membrane disintegration | MTT-assay | Bcap-37 | Breast cancer | IC50 : 10.52 µM |
| dbacp04141 | LK2(6)A(L) (Temporin-1CEa Analog peptide) | FVKLKKILNIINSIFKK | Synthetic construct | Cell membrane disintegration | MTT-assay | MDA-MB-231 | Breast cancer | IC50 : 34.74 µM |
| dbacp04142 | LK2(6)AN(2L) (Temporin-1CEa Analog peptide) | FVKLKKILNIILSIFKK | Synthetic construct | Cell membrane disintegration | MTT-assay | MCF-7 | Breast cancer | IC50 : 11 µM |
| dbacp04143 | LK2(6)AN(2L) (Temporin-1CEa Analog peptide) | FVKLKKILNIILSIFKK | Synthetic construct | Cell membrane disintegration | MTT-assay | Bcap-37 | Breast cancer | IC50 : 9.39 µM |
| dbacp04144 | LK2(6)AN(2L) (Temporin-1CEa Analog peptide) | FVKLKKILNIILSIFKK | Synthetic construct | Cell membrane disintegration | MTT-assay | MDA-MB-231 | Breast cancer | IC50 : 41.55 µM |
| dbacp04145 | LK3 (Temporin-1CEa Analog peptide) | FKKLKKIANIINSIFKK | Synthetic construct | Cell membrane disintegration | MTT-assay | MCF-7 | Breast cancer | IC50 : 27.72 µM |
| dbacp04146 | LK3 (Temporin-1CEa Analog peptide) | FKKLKKIANIINSIFKK | Synthetic construct | Cell membrane disintegration | MTT-assay | Bcap-37 | Breast cancer | IC50 : 25.04 µM |
| dbacp04147 | LK3 (Temporin-1CEa Analog peptide) | FKKLKKIANIINSIFKK | Synthetic construct | Cell membrane disintegration | MTT-assay | MDA-MB-231 | Breast cancer | IC50 : 224.8 µM |
| dbacp04155 | LL-37(1-12) | LLGDFFRKSKEK | LL-37,a series of peptide fragments | Cell membrane disintegration | MTT/MTS assay | KBv | Tumor | Not found |
| dbacp04156 | LL-37(1-12) | LLGDFFRKSKEK | LL-37,a series of peptide fragments | Cell membrane disintegration | MTT/MTS assay | KBv | Oral cancer | Not found |
| dbacp04157 | LL-37(1-12) | LLGDFFRKSKEK | LL-37,a series of peptide fragments | Cell membrane disintegration | MTT/MTS assay | HBMEC | Prostate cancer | Not found |
| dbacp04158 | LL-37(1-4,17-27) | LLGDFKRIVQRIKDF | LL-37,a series of peptide fragments | Cell membrane disintegration | MTT/MTS assay | KBv | Tumor | Not found |
| dbacp04159 | LL-37(1-4,17-27) | LLGDFKRIVQRIKDF | LL-37,a series of peptide fragments | Cell membrane disintegration | MTT/MTS assay | KBv | Oral cancer | Not found |
| dbacp04160 | LL-37(1-4,17-27) | LLGDFKRIVQRIKDF | LL-37,a series of peptide fragments | Cell membrane disintegration | MTT/MTS assay | HBMEC | Prostate cancer | Not found |
| dbacp04161 | LL-37(13-37) | IGKEFKRIVQRIKDFLRNLVPRTES | LL-37,a series of peptide fragments | Cell membrane disintegration | MTT/MTS assay | KBv | Tumor | LC50 : 39 µM |
| dbacp04162 | LL-37(13-37) | IGKEFKRIVQRIKDFLRNLVPRTES | LL-37,a series of peptide fragments | Cell membrane disintegration | MTT/MTS assay | KBv | Oral cancer | LC50 : 40 µM |
| dbacp04163 | LL-37(13-37) | IGKEFKRIVQRIKDFLRNLVPRTES | LL-37,a series of peptide fragments | Cell membrane disintegration | MTT/MTS assay | HBMEC | Prostate cancer | LC50 : 38 µM |
| dbacp04167 | LL-37(17-29) | FKRIVQRIKDFLR | LL-37,a series of peptide fragments | Cell membrane disintegration | MTT/MTS assay | KBv | Tumor | LC50 : 60 µM |
| dbacp04168 | LL-37(17-29) | FKRIVQRIKDFLR | LL-37,a series of peptide fragments | Cell membrane disintegration | MTT/MTS assay | KBv | Oral cancer | LC50 : 57 µM |
| dbacp04169 | LL-37(17-29) | FKRIVQRIKDFLR | LL-37,a series of peptide fragments | Cell membrane disintegration | MTT/MTS assay | HBMEC | Prostate cancer | LC50 : 55 µM |
| dbacp04177 | LL-37(17-32)b | FKRIVQRIKDFLRNLV | LL-37,a series of peptide fragments | Cell membrane disintegration | MTT/MTS assay | KBv | Tumor | LC50 : 30 µM |
| dbacp04178 | LL-37(17-32)b | FKRIVQRIKDFLRNLV | LL-37,a series of peptide fragments | Cell membrane disintegration | MTT/MTS assay | KBv | Oral cancer | LC50 : 30 µM |
| dbacp04179 | LL-37(17-32)b | FKRIVQRIKDFLRNLV | LL-37,a series of peptide fragments | Cell membrane disintegration | MTT/MTS assay | HBMEC | Prostate cancer | LC50 : 25 µM |
| dbacp04296 | LTX-302 | WKKW-Dip-KKWK | Synthetic peptide | Cell membrane disintegration | MTT/MTS assay | HT-29 | Colon cancer | IC50 : 75 ± 5 µM |
| dbacp04297 | LTX-302 | WKKW-Dip-KKWK | Synthetic peptide | Cell membrane disintegration | MTT/MTS assay | MT-1 | Breast cancer | IC50 : 73 ± 2 µM |
| dbacp04298 | LTX-302 | WKKW-Dip-KKWK | Synthetic peptide | Cell membrane disintegration | MTT/MTS assay | Kelly | Brain tumor | IC50 : 28 ± 0 µM |
| dbacp04299 | LTX-315 | KKWWKKW-Dip-K | Synthetic peptide | Cell membrane disintegration | MTT/MTS assay | HT-29 | Colon cancer | IC50 : 38 ± 3 µM |
| dbacp04300 | LTX-315 | KKWWKKW-Dip-K | Synthetic peptide | Cell membrane disintegration | MTT/MTS assay | MT-1 | Breast cancer | IC50 : 31 ± 3 µM |
| dbacp04301 | LTX-315 | KKWWKKW-Dip-K | Synthetic peptide | Cell membrane disintegration | MTT/MTS assay | Kelly | Brain tumor | IC50 : 14 ± 1 µM |
| dbacp04305 | LTX-318 | OOW-Dip-OOWWO | Synthetic peptide | Cell membrane disintegration | MTT/MTS assay | HT-29 | Colon cancer | IC50 : 248 ± 5 µM |
| dbacp04306 | LTX-318 | OOW-Dip-OOWWO | Synthetic peptide | Cell membrane disintegration | MTT/MTS assay | MT-1 | Breast cancer | IC50 : 216 ± 36 µM |
| dbacp04307 | LTX-318 | OOW-Dip-OOWWO | Synthetic peptide | Cell membrane disintegration | MTT/MTS assay | Kelly | Brain tumor | IC50 : 78 ± 7 µM |
| dbacp04315 | Lunasin | KTCENLADTFRGPCFATSNC | Lima bean | Cell membrane disintegration | Not specified | Not found | Colorectal cancer | Not found |
| dbacp04316 | Lunasin | KTCENLADTFRGPCFATSNC | Lima bean | Cell membrane disintegration | Not specified | Not found | Colorectal cancer | Not found |
| dbacp04425 | Macropin 1 | GFGMALKLLKKVL | The solitary bee | Cell membrane disintegration | MTT/XTT test | HUVEC | Not found | IC50 : 28 ± 6 μM |
| dbacp04426 | Macropin 1 | GFGMALKLLKKVL | The solitary bee | Cell membrane disintegration | MTT/XTT test | IEC | Not found | IC50 : 27 ± 7 μM |
| dbacp04427 | Macropin 1 | GFGMALKLLKKVL | The solitary bee | Cell membrane disintegration | MTT/XTT test | HeLa | Not found | IC50 : 10 ± 4 μM |
| dbacp04428 | Macropin 1 | GFGMALKLLKKVL | The solitary bee | Cell membrane disintegration | MTT/XTT test | SW | Not found | IC50 : 23 ± 4 μM |
| dbacp04429 | Macropin 1 | GFGMALKLLKKVL | The solitary bee | Cell membrane disintegration | MTT/XTT test | CEM | Not found | IC50 : 12 ± 6 μM |
| dbacp04432 | Macropin 2 | GTGLPMSERRKIMLMMR | The solitary bee | Cell membrane disintegration | MTT/XTT test | HUVEC | Not found | IC50 : >100 μM |
| dbacp04433 | Macropin 2 | GTGLPMSERRKIMLMMR | The solitary bee | Cell membrane disintegration | MTT/XTT test | IEC | Not found | IC50 : >100 μM |
| dbacp04434 | Macropin 2 | GTGLPMSERRKIMLMMR | The solitary bee | Cell membrane disintegration | MTT/XTT test | HeLa | Not found | IC50 : >100 μM |
| dbacp04435 | Macropin 2 | GTGLPMSERRKIMLMMR | The solitary bee | Cell membrane disintegration | MTT/XTT test | SW | Not found | IC50 : >100 μM |
| dbacp04436 | Macropin 2 | GTGLPMSERRKIMLMMR | The solitary bee | Cell membrane disintegration | MTT/XTT test | CEM | Not found | IC50 : 32 μM |
| dbacp04438 | Maculatin 1.1 | GLFVGVLAKVAAHVVPAIAEHF | Fringed Tree Frog, Australia | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp04439 | Maculatin 1.1 | GLFVGVLAKVAAHVVPAIAEHF | Skin secretions, Fringed Tree Frog, Australia | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp04440 | Maculatin 1.2 | GLFVGLAKVAAHNNPAIAEHFQA | Fringed Tree Frog, Australia | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp04441 | Maculatin 1.2 | GLFVGLAKVAAHNNPAIAEHFQA | Tapping green eyed frog, Australia | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp04472 | Maculatin 2.1 | GFVDFLKKVAGTIANVVT | Fringed Tree Frog, Australia | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp04473 | Maculatin 2.1 | GFVDFLKKVAGTIANVVT | Fringed Tree Frog, Australia | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp04474 | Maculatin 3.1 | GLLQTIKEKLESLESLAKGIVSGIQA | Fringed Tree Frog, Australia | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp04475 | Maculatin 3.1 | GLLQTIKEKLESLESLAKGIVSGIQA | Fringed Tree Frog, Australia | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp04570 | Mastoparan B | LKLKSIVSWAKKVL | Hornet | Cell membrane disintegration | Not specified | Not found | Colorectal cancer | Not found |
| dbacp04571 | Mastoparan B | LKLKSIVSWAKKVL | Hornet | Cell membrane disintegration | Not specified | Not found | Colorectal cancer | Not found |
| dbacp04599 | Maximin 1 | GIGTKILGGVKTALKGALKELASTYAN | Yunnan firebelly toad | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp04600 | Maximin 3 | GIGGKILSGLKTALKGAAKELASTYLH | Yunnan firebelly toad | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp04601 | Maximin 4 | GIGGVLLSAGKAALKGLAKVLAEKYAN | Yunnan firebelly toad | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp04602 | Maximin H1 | ILGPVISTIGGVLGGLLKNL | Yunnan firebelly toad | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp04606 | Maximin H5 | ILGPVLGLVSDTLDDVLGIL | Yunnan firebelly toad, China, Asia | Cell membrane disintegration | Not specified | Not found | Not found | MIC : 80 μM |
| dbacp04638 | Medusin-L1 | LLGMIPLAISAISALSKL | Lemur leaf frog | Cell membrane disintegration | Not specified | Not found | Colorectal cancer | Not found |
| dbacp04639 | Medusin-L1 (MDS-L1) (Phylloseptin-L1) (PLS-L1) | LLGMIPLAISAISALSKL | Lemur leaf frog | Cell membrane disintegration | Not specified | Not found | Colorectal cancer | Not found |
| dbacp04677 | MG2d | GIGKFLHSAKKWGKAFVGQIMNC | Synthetic | Cell membrane disintegration | MTT/MTS assay | HeLa | Cervical cancer | At 1 µM 90-100% viablity |
| dbacp04681 | Microcin E492 | GETDPNTQLLNDLGNnMAWGAALGAPGGLGSAALGAAGGALQTVGQGLIDHGPVNVFIPVLIGPSWNGSGSGYNSATSSSGSGS | Friedländer's bacillus | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp04682 | Microcin E492 | GETDPNTQLLNDLGNnMAWGAALGAPGGLGSAALGAAGGALQTVGQGLIDHGPVNVFIPVLIGPSWNGSGSGYNSATSSSGSGS | Human microbiota:gut, symbiont bacteria | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp04730 | N-1 | WKLFKKIPKFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 9.5 µM |
| dbacp04731 | N-1 | WKLFKKIPKFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | Jurkat | Blood cancer | IC50 : 12 µM |
| dbacp04732 | N-1 | WKLFKKIPKFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | K-562 | Leukemia cancer | IC50 : 6 µM |
| dbacp04733 | N-2 | FKLFKKIPKFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 11 µM |
| dbacp04734 | N-2 | FKLFKKIPKFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | Jurkat | Blood cancer | IC50 : 11 µM |
| dbacp04735 | N-2 | FKLFKKIPKFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | K-562 | Leukemia cancer | IC50 : 7 µM |
| dbacp04736 | N-3 | KWFKKIPKFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 17 µM |
| dbacp04737 | N-3 | KWFKKIPKFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | Jurkat | Blood cancer | IC50 : 17 µM |
| dbacp04738 | N-3 | KWFKKIPKFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | K-562 | Leukemia cancer | IC50 : 11 µM |
| dbacp04739 | N-3L | WFKKIPKFLHLLKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 5 µM |
| dbacp04740 | N-3L | KWFKKIPKFLHLLKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | Jurkat | Blood cancer | IC50 : 4 µM |
| dbacp04741 | N-3L | KWFKKIPKFLHLLKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | K-562 | Leukemia cancer | IC50 : 4.2 µM |
| dbacp04742 | N-4 | WFKKIPKFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 32 µM |
| dbacp04743 | N-4 | WFKKIPKFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | Jurkat | Blood cancer | IC50 : 23 µM |
| dbacp04744 | N-4 | WFKKIPKFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | K-562 | Leukemia cancer | IC50 : 24 µM |
| dbacp04745 | N-4L | WKKIPKFLHLLKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 5 µM |
| dbacp04746 | N-4L | WFKKIPKFLHLLKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | Jurkat | Blood cancer | IC50 : 6 µM |
| dbacp04747 | N-4L | WFKKIPKFLHLLKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | K-562 | Leukemia cancer | IC50 : 3 µM |
| dbacp04748 | N-5 | WKKIPKFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : < 100 µM |
| dbacp04749 | N-5 | WKKIPKFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | Jurkat | Blood cancer | IC50 : < 100 µM |
| dbacp04750 | N-5 | WKKIPKFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | K-562 | Leukemia cancer | IC50 : < 100 µM |
| dbacp04751 | N-5L | WKKIPKFLHLLKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 :17 µM |
| dbacp04752 | N-5L | WKKIPKFLHLLKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | Jurkat | Blood cancer | IC50 :14 µM |
| dbacp04753 | N-5L | WKKIPKFLHLLKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | K-562 | Leukemia cancer | IC50 :10 µM |
| dbacp04864 | NK-2 | KILRGVCKKIMRTFLRRISKDILTGKK | NK-lysin | Cell membrane disintegration | PI-uptake assay | NB LA-N-1 | Colorectal cancer | LD50 : 1-4 µM |
| dbacp04865 | NK-2 | KILRGVCKKIMRTFLRRISKDILTGKK | NK-lysin | Cell membrane disintegration | PI-uptake assay | SH-SY5Y | Brain tumor | LD50 : 1-4 µM |
| dbacp04866 | NK-2 | KILRGVCKKIMRTFLRRISKDILTGKK | NK-lysin | Cell membrane disintegration | PI-uptake assay | U-937 | Lymphoma cancer | LD50 : 30 µM |
| dbacp04867 | NK-2 | KILRGVCKKIMRTFLRRISKDILTGKK | NK-lysin | Cell membrane disintegration | PI-uptake assay | SW-480 | Leukemia cancer | LD50 : 1-4 µM |
| dbacp05048 | P18 | KWKFKKIPKFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 8 µM |
| dbacp05049 | P18 | KWKFKKIPKFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | Jurkat | Blood cancer | IC50 : 4 µM |
| dbacp05050 | P18 | KWKFKKIPKFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | K-562 | Leukemia cancer | IC50 : 3.5 µM |
| dbacp05243 | Pentadactylin | GLLDTLKGAAKNVVGSLASKVMEKL | South American bullfrog, skin secretion, Leptodactylus labyrinthicus | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp05434 | Peptide-1 | IELLQARGGC-Pem | Synthetic construct | Cell membrane disintegration | MTT/MTS assay | HL-60 | Leukemia cancer | IC50 : 2.17 µM |
| dbacp05435 | Peptide-1 | IELLQARGGC-Pem | Synthetic construct | Cell membrane disintegration | MTT/MTS assay | NCI-H358 | Lung cancer | IC50 : 4.63 mM |
| dbacp05436 | Peptide-2 | IELLQARGGC-Pem-GGRRRRRRRR | Synthetic construct | Cell membrane disintegration | MTT/MTS assay | HL-60 | Leukemia cancer | IC50 : 2.64 µM |
| dbacp05437 | Peptide-2 | IELLQARGGC-Pem-GGRRRRRRRR | Synthetic construct | Cell membrane disintegration | MTT/MTS assay | NCI-H358 | Lung cancer | IC50 : 2.19 µM |
| dbacp05445 | Peptide-3 | RRRRRRRRGGC-Pem | Synthetic construct | Cell membrane disintegration | MTT/MTS assay | HL-60 | Leukemia cancer | IC50 : 6.24 µM |
| dbacp05446 | Peptide-3 | RRRRRRRRGGC-Pem | Synthetic construct | Cell membrane disintegration | MTT/MTS assay | NCI-H358 | Lung cancer | IC50 : 8.41 µM |
| dbacp05507 | Phylloseptin | GLWSKIKEAAKAAGKAALNAVTGLVNQGDQPS | Lemur leaf frog | Cell membrane disintegration | Not specified | Not found | Colorectal cancer | Not found |
| dbacp05523 | Phylloseptin-L1 | LLGMIPLAISAISALSKL | Lemur leaf frog | Cell membrane disintegration | Not specified | Not found | Colorectal cancer | Not found |
| dbacp05524 | Phylloseptin-L1 | LLGMIPLAISAISALSKL | Skin secretion, Red-eyed leaf frog, South America | Cell membrane disintegration | Not specified | Not found | Colorectal cancer | Not found |
| dbacp05563 | Piscidin 1 | FFHHIFRGIVHVGKTIHRLVTG | Hybrid striped bass (Striped bass x White bass) | Cell membrane disintegration | Not specified | Not found | Breast cancer | Not found |
| dbacp05564 | Piscidin 1 | FFHHIFRGIVHVGKTIHRLVTG | Mainly mast cells, gill, skin, intestine, spleen, and anterior kidney, hybrid striped bass (Striped bass x White bass) | Cell membrane disintegration | Not specified | Not found | Breast cancer | Not found |
| dbacp05573 | Plantaricin A | KSSAYSLQMGATAIKQVKKLFKKWGW | Lactic acid bacteria | Cell membrane disintegration | Not specified | Not found | Colorectal cancer | Not found |
| dbacp05589 | Polybia-CP | ILGTILGLLKSL | Neotropical social wasp, Swarm-founding polistine wasp | Cell membrane disintegration | Not specified | Not found | Breast cancer | Not found |
| dbacp05590 | Polybia-CP (Pol-CP-NH2) (Polybia chemotactic peptide) | ILGTILGLLKSL | Neotropical social wasp, Swarm-founding polistine wasp | Cell membrane disintegration | Not specified | Not found | Breast cancer | Not found |
| dbacp05591 | Polybia-mastoparan-I | IDWKKLLDAAKQIL | Neotropical social wasp, Swarm-founding polistine wasp | Cell membrane disintegration | Not specified | Not found | Breast cancer | Not found |
| dbacp05592 | Polybia-mastoparan-I | IDWKKLLDAAKQIL | Neotropical social wasp, Swarm-founding polistine wasp | Cell membrane disintegration | Not specified | Not found | Breast cancer | Not found |
| dbacp05593 | Polybia-MPI | IDWKKLLDAAKQIL | Venom, social wasp | Cell membrane disintegration | Not specified | Not found | Breast cancer | Not found |
| dbacp05595 | Polybia-MPI | IDWKKLLDAAKQIL | Venom, social wasp | Cell membrane disintegration | Not specified | Not found | Breast cancer | Not found |
| dbacp05625 | PR-39 | RRRPRPPYLPRPRPPPFFPPRLPPRIPPGFPPRFPPRFP | Pig neutrophils | Cell membrane disintegration | Not specified | Not found | Not found | MIC : 2.5 mM |
| dbacp05694 | PST13-RK | KKKFPWWWPFKKK | Derivative of tritrpticin | Cell membrane disintegration | MTT/MTS assay | A-549 | Lung cancer | IC50 : 90 µg/ml |
| dbacp05695 | PST13-RK | KKKFPWWWPFKKK | Derivative of tritrpticin | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 80 µg/ml |
| dbacp05791 | Pyrularia thionin | KSCCRNTWARNCYNVCRLPGTISREICAKKCDCKIISGTTCPSDYPK | Buffalo nut | Cell membrane disintegration | Not specified | Not found | Colorectal cancer | Not found |
| dbacp05792 | Pyrularia thionin | KSCCRNTWARNCYNVCRLPGTISREICAKKCDCKIISGTTCPSDYPK | Buffalo nut | Cell membrane disintegration | Not specified | Not found | Colorectal cancer | Not found |
| dbacp05820 | R8 | CALRRRRRRRR | Not found | Cell membrane disintegration | SPR assay | B16 | Mouse Melanoma | Not found |
| dbacp05821 | R8 | CALRRRRRRRR | Not found | Cell membrane disintegration | SPR assay | A549 | Human lung adenocarcinoma | Not found |
| dbacp05912 | Ranatuerin-2Ya | GLMDTIKGVAKTVAASWLDKLKCKITGC | North America, leopard frog | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp05913 | Ranatuerin-2Ya | GLMDTIKGVAKTVAASWLDKLKCKITGC | North America, leopard frog | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp05943 | RGD-La | RGDLLRHVVKILEKYL | Arg-Gly-Asp(RGD) tripeptide ana temporins | Cell membrane disintegration | MTT/MTS assay | SW-1116 | Colorectal cancer | 72.69 Inhibition ratio at 50 µg/ml |
| dbacp05944 | RGD-La | RGDLLRHVVKILEKYL | Arg-Gly-Asp(RGD) tripeptide ana temporins | Cell membrane disintegration | MTT/MTS assay | SMMC-7721 | Liver cancer | 70.39 Inhibition ratio at 50 µg/ml |
| dbacp05945 | RGD-La | RGDLLRHVVKILEKYL | Arg-Gly-Asp(RGD) tripeptide ana temporins | Cell membrane disintegration | MTT/MTS assay | HeLa | Cervical cancer | 73.09 Inhibition ratio at 50 µg/ml |
| dbacp05946 | RGD-La | RGDLLRHVVKILEKYL | Arg-Gly-Asp(RGD) tripeptide ana temporins | Cell membrane disintegration | MTT/MTS assay | HepG-2 | Liver cancer | 60.22 Inhibition ratio at 50 µg/ml |
| dbacp05947 | RGD-La | RGDLLRHVVKILEKYL | Arg-Gly-Asp(RGD) tripeptide ana temporins | Cell membrane disintegration | MTT/MTS assay | BGC-823 | Gastric cancer | 62.49 Inhibition ratio at 50 µg/ml |
| dbacp05948 | RGD-La | RGDLLRHVVKILEKYL | Arg-Gly-Asp(RGD) tripeptide ana temporins | Cell membrane disintegration | MTT/MTS assay | A-549 | Lung cancer | 47.26Inhibition ratio at 50 µg/ml |
| dbacp05949 | RGD-La | RGDLLRHVVKILEKYL | Arg-Gly-Asp(RGD) tripeptide ana temporins | Cell membrane disintegration | MTT/MTS assay | HL7702 | Liver cancer | 36.25 Inhibition ratio at 50 µg/ml |
| dbacp05950 | RGD-La | RGDLLRHVVKILEKYL | Arg-Gly-Asp(RGD) tripeptide ana temporins | Cell membrane disintegration | MTT/MTS assay | HEK-293T | Renal cancer | 27.86 Inhibition ratio at 50 µg/ml |
| dbacp05951 | RGD-La | RGDLLRHVVKILEKYL | Arg-Gly-Asp(RGD) tripeptide ana temporins | Cell membrane disintegration | MTT/MTS assay | MEC | Breast cancer | 19.76 Inhibition ratio at 50 µg/ml |
| dbacp05952 | RGD-Las | RGDLLRHVVKILSKYL | Arg-Gly-Asp(RGD) tripeptide ana temporins | Cell membrane disintegration | MTT/MTS assay | SW-1116 | Colorectal cancer | 81.465 Inhibition ratio at 50 µg/ml |
| dbacp05953 | RGD-Las | RGDLLRHVVKILSKYL | Arg-Gly-Asp(RGD) tripeptide ana temporins | Cell membrane disintegration | MTT/MTS assay | SMMC-7721 | Liver cancer | 86.175 Inhibition ratio at 50 µg/ml |
| dbacp05954 | RGD-Las | RGDLLRHVVKILSKYL | Arg-Gly-Asp(RGD) tripeptide ana temporins | Cell membrane disintegration | MTT/MTS assay | HeLa | Cervical cancer | 78.045 Inhibition ratio at 50 µg/ml |
| dbacp05955 | RGD-Las | RGDLLRHVVKILSKYL | Arg-Gly-Asp(RGD) tripeptide ana temporins | Cell membrane disintegration | MTT/MTS assay | HepG-2 | Liver cancer | 73.07 Inhibition ratio at 50 µg/ml |
| dbacp05956 | RGD-Las | RGDLLRHVVKILSKYL | Arg-Gly-Asp(RGD) tripeptide ana temporins | Cell membrane disintegration | MTT/MTS assay | BGC-823 | Gastric cancer | 73.705 Inhibition ratio at 50 µg/ml |
| dbacp05957 | RGD-Las | RGDLLRHVVKILSKYL | Arg-Gly-Asp(RGD) tripeptide ana temporins | Cell membrane disintegration | MTT/MTS assay | A-549 | Lung cancer | 52.50 Inhibition ratio at 50 µg/ml |
| dbacp05958 | RGD-Las | RGDLLRHVVKILSKYL | Arg-Gly-Asp(RGD) tripeptide ana temporins | Cell membrane disintegration | MTT/MTS assay | HL7702 | Liver cancer | 38.13 Inhibition ratio at 50 µg/ml |
| dbacp05959 | RGD-Las | RGDLLRHVVKILSKYL | Arg-Gly-Asp(RGD) tripeptide ana temporins | Cell membrane disintegration | MTT/MTS assay | HEK-293T | Renal cancer | 32.52 Inhibition ratio at 50 µg/ml |
| dbacp05960 | RGD-Las | RGDLLRHVVKILSKYL | Arg-Gly-Asp(RGD) tripeptide ana temporins | Cell membrane disintegration | MTT/MTS assay | MEC | Breast cancer | 29.33 Inhibition ratio at 50 µg/ml |
| dbacp06061 | Sesquin | KTCENLADTY | Seeds, Ground bean | Cell membrane disintegration | Not specified | Not found | Colorectal cancer | Not found |
| dbacp06062 | Sesquin | KTCENLADTY | Seeds, Ground bean | Cell membrane disintegration | Not specified | Not found | Colorectal cancer | Not found |
| dbacp06117 | SK84 | SQLGDLGSGAGQGGGGGGSIRAAGGAFGKLEAAREEEFFYKKQKEQLERLKNDQIHQAEFHHQQIKEHEEAIQRHKDFLNNLHK | Fruit fly | Cell membrane disintegration | MTS/PES colorimetric assay | HepG2 | Liver cancer | IC50 : 92 μM |
| dbacp06118 | SK84 | SQLGDLGSGAGQGGGGGGSIRAAGGAFGKLEAAREEEFFYKKQKEQLERLKNDQIHQAEFHHQQIKEHEEAIQRHKDFLNNLHK | Fruit fly | Cell membrane disintegration | MTS/PES colorimetric assay | HepG2 | Breast cancer | IC50 : 92 μM |
| dbacp06119 | SK84 | SQLGDLGSGAGQGGGGGGSIRAAGGAFGKLEAAREEEFFYKKQKEQLERLKNDQIHQAEFHHQQIKEHEEAIQRHKDFLNNLHK | Fruit fly | Cell membrane disintegration | MTS/PES colorimetric assay | MCF-7 | Liver cancer | IC50 : 50 μM |
| dbacp06120 | SK84 | SQLGDLGSGAGQGGGGGGSIRAAGGAFGKLEAAREEEFFYKKQKEQLERLKNDQIHQAEFHHQQIKEHEEAIQRHKDFLNNLHK | Fruit fly | Cell membrane disintegration | MTS/PES colorimetric assay | MCF-7 | Breast cancer | IC50 : 50 μM |
| dbacp06121 | SK84 | SQLGDLGSGAGQGGGGGGSIRAAGGAFGKLEAAREEEFFYKKQKEQLERLKNDQIHQAEFHHQQIKEHEEAIQRHKDFLNNLHK | Fruit fly | Cell membrane disintegration | MTS/PES colorimetric assay | THP-1 | Liver cancer | IC50 : 35 μM |
| dbacp06122 | SK84 | SQLGDLGSGAGQGGGGGGSIRAAGGAFGKLEAAREEEFFYKKQKEQLERLKNDQIHQAEFHHQQIKEHEEAIQRHKDFLNNLHK | Fruit fly | Cell membrane disintegration | MTS/PES colorimetric assay | THP-1 | Breast cancer | IC50 : 35 μM |
| dbacp06196 | Tat (47-57) | YGRKKRRQRRR | Synthetic construct | Cell membrane disintegration | MTT/MTS assay | HeLa | Cervical cancer | At 1 µM 90 - 100% viablity |
| dbacp06197 | Tat (47-57) | YGRKKRRQRRR | Synthetic construct | Cell membrane disintegration | MTT/MTS assay | HeLa | Cervical cancer | At 10 µM 80% viablity |
| dbacp06198 | Tat (47-57) | YGRKKRRQRRR | Synthetic construct | Cell membrane disintegration | MTT/MTS assay | HeLa | Cervical cancer | At 100 µM 60% viablity |
| dbacp06227 | Temporin A | FLPLIGRVLSGIL | Common frog | Cell membrane disintegration | MTT/MTS assay | U-937 | Lymphoma cancer | 15% cytotoxicity at 0.5 µg/ml |
| dbacp06228 | Temporin A | FLPLIGRVLSGIL | European common frog | Cell membrane disintegration | MTT/MTS assay | U-937 | Lymphoma cancer | 15% cytotoxicity at 0.5 µg/ml |
| dbacp06229 | Temporin L | FVQWFSKFLGRIL | European common frog | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp06230 | Temporin L | FVQWFSKFLGRIL | European common frog | Cell membrane disintegration | MTT/MTS assay | U-938 | Lymphoma cancer | 15% cytotoxicity at 0.5 µg/ml |
| dbacp06239 | Temporin-1CEb | ILPILSLIGGLLGK | Chinese brown frog or Asiatic grass frog, China, Asia | Cell membrane disintegration | Not specified | Not found | Breast cancer | Not found |
| dbacp06240 | Temporin-1CEb | ILPILSLIGGLLGK | Chinese brown frog or Asiatic grass frog, China, Asia | Cell membrane disintegration | Not specified | Not found | Breast cancer | Not found |
| dbacp06246 | Temporin-ALa | FLPIVGKLLSGLSGLL | The rufous-spotted torrent frog, China, Asia | Cell membrane disintegration | Not specified | HepG2 | Not found | Not found |
| dbacp06248 | Temporin-La | LLRHVVKILEKYL | Temporins family | Cell membrane disintegration | MTT/MTS assay | SW-1116 | Colorectal cancer | 57.62 inhibition ratio at 50 µg/ml |
| dbacp06249 | Temporin-La | LLRHVVKILEKYL | Temporins family | Cell membrane disintegration | MTT/MTS assay | SMMC-7721 | Liver cancer | 52.77 inhibition ratio at 50 µg/ml |
| dbacp06250 | Temporin-La | LLRHVVKILEKYL | Temporins family | Cell membrane disintegration | MTT/MTS assay | HeLa | Cervical cancer | 52.32 inhibition ratio at 50 µg/ml |
| dbacp06251 | Temporin-La | LLRHVVKILEKYL | Temporins family | Cell membrane disintegration | MTT/MTS assay | HepG-2 | Liver cancer | 50.90 inhibition ratio at 50 µg/ml |
| dbacp06252 | Temporin-La | LLRHVVKILEKYL | Temporins family | Cell membrane disintegration | MTT/MTS assay | BGC-823 | Gastric cancer | 48.19 inhibition ratio at 50 µg/ml |
| dbacp06253 | Temporin-La | LLRHVVKILEKYL | Temporins family | Cell membrane disintegration | MTT/MTS assay | A-549 | Lung cancer | 45.62 inhibition ratio at 50 µg/ml |
| dbacp06254 | Temporin-La | LLRHVVKILEKYL | Temporins family | Cell membrane disintegration | MTT/MTS assay | HL7702 | Liver cancer | 37.22 inhibition ratio at 50 µg/ml |
| dbacp06255 | Temporin-La | LLRHVVKILEKYL | Temporins family | Cell membrane disintegration | MTT/MTS assay | HEK-293T | Renal cancer | 30.82 inhibition ratio at 50 µg/ml |
| dbacp06257 | Temporin-Las | LLRHVVKILSKYL | Temporins family | Cell membrane disintegration | MTT/MTS assay | SW-1116 | Colorectal cancer | 62.73 inhibition ratio at 50 µg/ml |
| dbacp06258 | Temporin-Las | LLRHVVKILSKYL | Temporins family | Cell membrane disintegration | MTT/MTS assay | SMMC-7721 | Liver cancer | 59.37 inhibition ratio at 50 µg/ml |
| dbacp06259 | Temporin-Las | LLRHVVKILSKYL | Temporins family | Cell membrane disintegration | MTT/MTS assay | HeLa | Cervical cancer | 56.81 inhibition ratio at 50 µg/ml |
| dbacp06260 | Temporin-Las | LLRHVVKILSKYL | Temporins family | Cell membrane disintegration | MTT/MTS assay | HepG-2 | Liver cancer | 55.98 inhibition ratio at 50 µg/ml |
| dbacp06261 | Temporin-Las | LLRHVVKILSKYL | Temporins family | Cell membrane disintegration | MTT/MTS assay | BGC-823 | Gastric cancer | 50.85 inhibition ratio at 50 µg/ml |
| dbacp06262 | Temporin-Las | LLRHVVKILSKYL | Temporins family | Cell membrane disintegration | MTT/MTS assay | A-549 | Lung cancer | 50.64 inhibition ratio at 50 µg/ml |
| dbacp06263 | Temporin-Las | LLRHVVKILSKYL | Temporins family | Cell membrane disintegration | MTT/MTS assay | HL7702 | Liver cancer | 37.00 inhibition ratio at 50 µg/ml |
| dbacp06264 | Temporin-Las | LLRHVVKILSKYL | Temporins family | Cell membrane disintegration | MTT/MTS assay | HEK-293T | Renal cancer | 30.90 inhibition ratio at 50 µg/ml |
| dbacp06265 | Temporin-Las | LLRHVVKILEKYL | Temporins family | Cell membrane disintegration | MTT/MTS assay | MEC | Breast cancer | 24.15 inhibition ratio at 50 µg/ml |
| dbacp06266 | Temporin-Las | LLRHVVKILSKYL | Temporins family | Cell membrane disintegration | MTT/MTS assay | MEC | Breast cancer | 27.99 inhibition ratio at 50 µg/ml |
| dbacp06349 | Tritrpticin | VRRFPWWWPFLRR | Derivative of tritrpticin | Cell membrane disintegration | MTT/MTS assay | A-549 | Lung cancer | IC50 : > 200 µg/ml |
| dbacp06350 | Tritrpticin | VRRFPWWWPFLRR | Derivative of tritrpticin | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 142 µg/ml |
| dbacp06455 | Varv peptide A | GLPVCGETCVGGTCNTPGCSCSWPVCTRN | Field pansy,Sweet violet, Wild pansy, Violets or Pansies, Philippine violet herb, and Alpine yellow-violet | Cell membrane disintegration | Not specified | Not found | Fibrosarcoma | Not found |
| dbacp06456 | Varv peptide A | GLPVCGETCVGGTCNTPGCSCSWPVCTRN | Field pansy,Sweet violet, Wild pansy, Violets or Pansies, Philippine violet herb, and Alpine yellow-violet | Cell membrane disintegration | Not specified | Not found | Fibrosarcoma | Not found |
| dbacp06475 | Varv peptide F | GVPICGETCTLGTCYTAGCSCSWPVCTRN | Field pansy | Cell membrane disintegration | Not specified | Not found | Leukemia cancer | Not found |
| dbacp06476 | Varv peptide F | GVPICGETCTLGTCYTAGCSCSWPVCTRN | Field pansy | Cell membrane disintegration | Not specified | Not found | Leukemia cancer | Not found |
| dbacp06494 | Vibi E | GIPCAESCVWIPCTVTALIGCGCSNKVCYN | Alpine violet, Viola biflora | Cell membrane disintegration | Not specified | Not found | Leukemia cancer | Not found |
| dbacp06495 | Vibi E | GIPCAESCVWIPCTVTALIGCGCSNKVCYN | Alpine violet, Viola biflora | Cell membrane disintegration | Not specified | Not found | Lung cancer | Not found |
| dbacp06496 | Vibi G | GTFPCGESCVFIPCLTSAIGCSCKSKVCYKN | Alpine violet, Viola biflora | Cell membrane disintegration | Not specified | Not found | Skin cancer | Not found |
| dbacp06497 | Vibi G | GTFPCGESCVFIPCLTSAIGCSCKSKVCYKN | Alpine violet, Viola biflora | Cell membrane disintegration | Not specified | Not found | Lung cancer | Not found |
| dbacp06498 | Vibi H | GLLPCAESCVYIPCLTTVIGCSCKSKVCYKN | Alpine violet, Viola biflora | Cell membrane disintegration | Not specified | Not found | Lung cancer | Not found |
| dbacp06499 | Vibi H | GLLPCAESCVYIPCLTTVIGCSCKSKVCYKN | Alpine violet, Viola biflora | Cell membrane disintegration | Not specified | Not found | Lung cancer | Not found |
| dbacp06516 | Viscotoxin 1-PS | KSCCPNTTGRNIYNTCRFGGGSREVCARISGCKIISASTCPSDYPK | European mistletoe | Cell membrane disintegration | Not specified | Not found | Breast cancer | Not found |
| dbacp06517 | Viscotoxin 1-Ps | KSCCPNTTGRNIYNTCRFGGGSREVCARISGCKIISASTCPSDYPK | The European mistletoe | Cell membrane disintegration | Not specified | Not found | Colorectal cancer | Not found |
| dbacp06518 | Viscotoxin A1 | KSCCPNTTGRNIYNTCRLTGSSRETCAKLSGCKIISASTCPSNYPK | European mistletoe | Cell membrane disintegration | Not specified | Not found | Breast cancer | Not found |
| dbacp06519 | Viscotoxin A1 | KSCCPNTTGRNIYNTCRLTGSSRETCAKLSGCKIISASTCPSNYPK | Seeds, European mistletoe | Cell membrane disintegration | Not specified | Not found | Colorectal cancer | Not found |
| dbacp06520 | Viscotoxin A2 | KSCCPNTTGRNIYNTCRFGGGSRQVCASLSGCKIISASTCPSDYPK | European mistletoe | Cell membrane disintegration | Not specified | Not found | Colorectal cancer | Not found |
| dbacp06521 | Viscotoxin A2 | KSCCPNTTGRNIYNTCRFGGGSRQVCASLSGCKIISASTCPSDYPK | European mistletoe | Cell membrane disintegration | Not specified | Not found | Colorectal cancer | Not found |
| dbacp06522 | Viscotoxin A3 | KSCCPNTTGRNIYNACRLTGAPRPTCAKLSGCKIISGSTCPSDYPK | The European mistletoe | Cell membrane disintegration | Not specified | Not found | Breast cancer | Not found |
| dbacp06523 | Viscotoxin A3 | KSCCPNTTGRNIYNACRLTGAPRPTCAKLSGCKIISGSTCPSDYPK | The European mistletoe | Cell membrane disintegration | Not specified | Not found | Breast cancer | Not found |
| dbacp06524 | Viscotoxin B | KSCCPNTTGRNIYNTCRLGGGSRERCASLSGCKIISASTCPSDYPK | European mistletoe | Cell membrane disintegration | Not specified | Not found | Colorectal cancer | Not found |
| dbacp06525 | Viscotoxin B | KSCCPNTTGRNIYNTCRLGGGSRERCASLSGCKIISASTCPSDYPK | European mistletoe | Cell membrane disintegration | Not specified | Not found | Colorectal cancer | Not found |
| dbacp06526 | Viscotoxin B2 | KSCCKNTTGRNIYNTCRFAGGSRERCAKLSGCKIISASTCPSDYPK | Korean mistletoe | Cell membrane disintegration | Not specified | Not found | Breast cancer | Not found |
| dbacp06527 | Viscotoxin B2 | KSCCKNTTGRNIYNTCRFAGGSRERCAKLSGCKIISASTCPSDYPK | Korean mistletoe | Cell membrane disintegration | Not specified | Not found | Breast cancer | Not found |
| dbacp06528 | Viscotoxin C | KSCCPNTTGRNIYNTCRFAGGSRERCAKLSGCKIISASTCPSDYPK | The Asiatic Viscum | Cell membrane disintegration | Not specified | Not found | Colorectal cancer | Not found |
| dbacp06529 | Viscotoxin C1 | KSCCPNTTGRNIYNTCRFAGGSRERCAKLSGCKIISASTCPSDYPK | The Asiatic Viscum | Cell membrane disintegration | Not specified | Not found | Breast cancer | Not found |